| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone modifying activity | NCOA3 SETD1B CREBBP ATXN3L SIRT2 BRPF1 PRKAA1 NCOA1 METTL8 PRDM16 PHF10 EP300 | 2.86e-08 | 229 | 128 | 12 | GO:0140993 |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 3.45e-08 | 51 | 128 | 7 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 5.92e-08 | 55 | 128 | 7 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.10e-07 | 60 | 128 | 7 | GO:0034212 | |
| GeneOntologyMolecularFunction | chromatin binding | TPR NCOA3 TCF4 ATRX SMC1A CREBBP MEIS1 CTCFL SIRT2 PSIP1 PRKAA1 NCOA1 MLLT1 CHD6 ASXL2 ELK4 PRDM15 PHF10 EP300 | 2.48e-07 | 739 | 128 | 19 | GO:0003682 |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 3.03e-07 | 102 | 128 | 8 | GO:0016410 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 6.83e-07 | 78 | 128 | 7 | GO:0008080 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 4.78e-06 | 104 | 128 | 7 | GO:0016407 | |
| GeneOntologyMolecularFunction | transcription factor binding | BDP1 NCOA3 TCF4 TBX3 NACA XPC CREBBP ATXN3L SIRT2 PSIP1 PER2 NCOA1 CHD6 USF1 PRDM16 EP300 HTT | 6.47e-06 | 753 | 128 | 17 | GO:0008134 |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 8.86e-06 | 21 | 128 | 4 | GO:0042975 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 2.32e-05 | 238 | 128 | 9 | GO:0016747 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.61e-05 | 303 | 128 | 10 | GO:0003713 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 4.08e-05 | 2 | 128 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 4.08e-05 | 2 | 128 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 4.43e-05 | 31 | 128 | 4 | GO:0140033 | |
| GeneOntologyMolecularFunction | histone binding | 5.38e-05 | 265 | 128 | 9 | GO:0042393 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA3 TCF4 NACA TRIM31 XPC CREBBP PSIP1 PER2 TCF25 NCOA1 PRDM16 PHF10 EP300 | 6.67e-05 | 562 | 128 | 13 | GO:0003712 |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 9.03e-05 | 37 | 128 | 4 | GO:0043425 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 9.03e-05 | 37 | 128 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.22e-04 | 3 | 128 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TPR NCOA3 TCF4 PAG1 NACA TRIM31 SPAG9 XPC CREBBP ZZZ3 PSIP1 PER2 MDC1 TCF25 NCOA1 PHF14 PRDM16 PHF10 EP300 | 1.49e-04 | 1160 | 128 | 19 | GO:0030674 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA3 TCF4 TBX3 XPC CREBBP SIRT2 PSIP1 PER2 NCOA1 USF1 PRDM16 EP300 | 3.69e-04 | 582 | 128 | 12 | GO:0140297 |
| GeneOntologyMolecularFunction | molecular adaptor activity | TPR NCOA3 TCF4 PAG1 NACA TRIM31 SPAG9 XPC DZIP1 CREBBP ZZZ3 PSIP1 PER2 MDC1 TCF25 NCOA1 PHF14 PRDM16 PHF10 EP300 | 3.92e-04 | 1356 | 128 | 20 | GO:0060090 |
| GeneOntologyMolecularFunction | acyltransferase activity | NCOA3 MYCBP2 RBBP6 TRIM31 CREBBP SIRT2 NMT2 BRPF1 MIB1 NCOA1 METTL8 LONRF2 PHF10 EP300 | 4.54e-04 | 775 | 128 | 14 | GO:0016746 |
| GeneOntologyMolecularFunction | histone reader activity | 6.01e-04 | 26 | 128 | 3 | GO:0140566 | |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 6.01e-04 | 6 | 128 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 7.60e-04 | 64 | 128 | 4 | GO:0140296 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 9.20e-04 | 30 | 128 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.36e-03 | 127 | 128 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | p53 binding | 1.52e-03 | 77 | 128 | 4 | GO:0002039 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.09e-03 | 140 | 128 | 5 | GO:0001221 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.17e-03 | 441 | 128 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 2.30e-03 | 41 | 128 | 3 | GO:0140463 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 2.53e-03 | 213 | 128 | 6 | GO:0008168 | |
| GeneOntologyMolecularFunction | mRNA methyltransferase activity | 3.04e-03 | 13 | 128 | 2 | GO:0008174 | |
| GeneOntologyMolecularFunction | myosin II binding | 3.04e-03 | 13 | 128 | 2 | GO:0045159 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 3.25e-03 | 224 | 128 | 6 | GO:0016741 | |
| GeneOntologyMolecularFunction | beta-tubulin binding | 3.82e-03 | 49 | 128 | 3 | GO:0048487 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 4.05e-03 | 15 | 128 | 2 | GO:0010484 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BDP1 TPR NCOA3 TCF4 SETD1B ATRX HJURP RSF1 CHD9 CREBBP HMG20A CTCFL SIRT2 ZZZ3 PSIP1 PER2 BRPF1 MDC1 PRKAA1 BRD9 MKI67 SENP6 NCOA1 PHF14 CHD6 PRDM16 PHF10 EP300 TDRD12 | 2.33e-12 | 999 | 128 | 29 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | TPR NCOA3 SETD1B ATRX HJURP RSF1 CHD9 CREBBP HMG20A CTCFL SIRT2 ZZZ3 PSIP1 PER2 BRPF1 MDC1 PRKAA1 BRD9 MKI67 NCOA1 PHF14 CHD6 PRDM16 PHF10 EP300 TDRD12 | 3.92e-11 | 896 | 128 | 26 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | TPR NCOA3 SETD1B ATRX HJURP RSF1 CHD9 CREBBP CTCFL SIRT2 PSIP1 PER2 BRPF1 PRKAA1 BRD9 NCOA1 CHD6 PRDM16 PHF10 EP300 TDRD12 | 5.74e-09 | 741 | 128 | 21 | GO:0006338 |
| GeneOntologyBiologicalProcess | tubulin deacetylation | 1.37e-05 | 24 | 128 | 4 | GO:0090042 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TPR TCF4 TBX3 NACA ETV3 CREBBP HMG20A SIRT2 PER2 PKIA TCF25 PHF14 ASXL2 ELK4 IRX2 PRDM16 ZHX1 MAGEC2 EP300 | 2.68e-05 | 1053 | 128 | 19 | GO:0000122 |
| GeneOntologyCellularComponent | chromatin | NCOA3 TCF4 TBX3 ATRX RSF1 ETV3 XPC CREBBP MEIS1 PRDM10 SIRT2 ZZZ3 PSIP1 BRPF1 PRKAA1 BRD9 ANKRD11 NCOA1 PHF14 TNKS1BP1 CHD6 ELK4 USF1 IRX2 PHF10 ZHX1 EP300 | 2.47e-07 | 1480 | 128 | 27 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | BDP1 NCOA3 TCF4 TBX3 ETV3 CREBBP MEIS1 PRDM10 PER2 NCOA1 USF1 PRDM16 EP300 | 7.63e-05 | 596 | 128 | 13 | GO:0005667 |
| HumanPheno | Square face | 4.50e-06 | 16 | 38 | 4 | HP:0000321 | |
| HumanPheno | Absent speech | TCF4 SMC1A IQSEC2 COG3 CREBBP CYFIP2 SHROOM4 MAST1 MACF1 FGF13 PRDM16 EP300 HTT | 8.18e-06 | 436 | 38 | 13 | HP:0001344 |
| HumanPheno | Deficiency of speech development | TCF4 SMC1A IQSEC2 COG3 CREBBP CYFIP2 SHROOM4 MAST1 MACF1 FGF13 PRDM16 EP300 HTT | 1.58e-05 | 463 | 38 | 13 | HP:0002116 |
| HumanPheno | Motor stereotypy | 2.57e-05 | 280 | 38 | 10 | HP:0000733 | |
| HumanPheno | Shawl scrotum | 2.98e-05 | 25 | 38 | 4 | HP:0000049 | |
| HumanPheno | Restricted or repetitive behaviors or interests | TPR TCF4 ATRX SMC1A IQSEC2 CREBBP MACF1 FGF13 PRDM16 EP300 HTT | 4.89e-05 | 368 | 38 | 11 | HP:0031432 |
| HumanPheno | Plantar crease between first and second toes | 5.42e-05 | 2 | 38 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 5.42e-05 | 2 | 38 | 2 | HP:0034227 | |
| HumanPheno | Triangular nasal tip | 5.42e-05 | 2 | 38 | 2 | HP:0000451 | |
| HumanPheno | High axial triradius | 5.42e-05 | 2 | 38 | 2 | HP:0001042 | |
| HumanPheno | Perseverative thought | TPR TCF4 ATRX SMC1A IQSEC2 CREBBP MACF1 FGF13 PRDM16 EP300 HTT | 6.11e-05 | 377 | 38 | 11 | HP:0030223 |
| HumanPheno | Disordered formal thought process | TPR TCF4 ATRX SMC1A IQSEC2 CREBBP MACF1 FGF13 PRDM16 EP300 HTT | 7.59e-05 | 386 | 38 | 11 | HP:0025769 |
| HumanPheno | Abnormal thought pattern | TPR TCF4 ATRX SMC1A IQSEC2 CREBBP MACF1 FGF13 PRDM16 EP300 HTT | 1.15e-04 | 404 | 38 | 11 | HP:5200269 |
| HumanPheno | Laryngeal cartilage malformation | 1.62e-04 | 3 | 38 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.62e-04 | 3 | 38 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.62e-04 | 3 | 38 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.62e-04 | 3 | 38 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.62e-04 | 3 | 38 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.62e-04 | 3 | 38 | 2 | HP:0005895 | |
| HumanPheno | Intellectual disability, severe | 2.77e-04 | 371 | 38 | 10 | HP:0010864 | |
| HumanPheno | Trichiasis | 3.22e-04 | 4 | 38 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 3.22e-04 | 4 | 38 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 3.22e-04 | 4 | 38 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 3.22e-04 | 4 | 38 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 3.22e-04 | 4 | 38 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 3.22e-04 | 4 | 38 | 2 | HP:0031207 | |
| HumanPheno | EEG abnormality | SETD1B SMC1A IQSEC2 ARFGEF2 XPC COG3 CREBBP CYFIP2 ANKRD11 FGF13 PRDM16 EP300 | 4.15e-04 | 548 | 38 | 12 | HP:0002353 |
| HumanPheno | Deep plantar creases | 4.64e-04 | 21 | 38 | 3 | HP:0001869 | |
| HumanPheno | Delayed speech and language development | TCF4 SETD1B SMC1A IQSEC2 ACBD5 COG3 CREBBP CYFIP2 SHROOM4 BRPF1 ANKRD11 MAST1 MACF1 FGF13 ASXL2 PRDM16 EP300 HTT | 4.65e-04 | 1123 | 38 | 18 | HP:0000750 |
| HumanPheno | Short 5th toe | 5.34e-04 | 5 | 38 | 2 | HP:0011917 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 5.34e-04 | 5 | 38 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 5.34e-04 | 5 | 38 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 5.34e-04 | 5 | 38 | 2 | HP:0030421 | |
| HumanPheno | Secondary microcephaly | 5.79e-04 | 200 | 38 | 7 | HP:0005484 | |
| HumanPheno | Autism | 5.88e-04 | 264 | 38 | 8 | HP:0000717 | |
| HumanPheno | Panic attack | 6.84e-04 | 55 | 38 | 4 | HP:0025269 | |
| HumanPheno | Facial hypertrichosis | 6.92e-04 | 206 | 38 | 7 | HP:0002219 | |
| HumanPheno | Non-epileptic seizure | 7.33e-04 | 56 | 38 | 4 | HP:0033052 | |
| HumanPheno | Abnormal eyebrow morphology | TCF4 TBX3 SETD1B SMC1A IQSEC2 GPR101 CREBBP CYFIP2 ANKRD11 CHD6 ASXL2 PRDM16 EP300 | 7.65e-04 | 674 | 38 | 13 | HP:0000534 |
| HumanPheno | Large foramen magnum | 7.98e-04 | 6 | 38 | 2 | HP:0002700 | |
| HumanPheno | Hypertrichosis | ATRX SMC1A IQSEC2 GPR101 CREBBP SHROOM4 ANKRD11 ASXL2 PRDM16 EP300 | 8.23e-04 | 425 | 38 | 10 | HP:0000998 |
| HumanPheno | Language impairment | TCF4 SETD1B SMC1A IQSEC2 ACBD5 COG3 CREBBP CYFIP2 SHROOM4 BRPF1 ANKRD11 MAST1 MACF1 FGF13 ASXL2 PRDM16 EP300 HTT | 8.57e-04 | 1178 | 38 | 18 | HP:0002463 |
| HumanPheno | Minor feet anomalies | 8.85e-04 | 26 | 38 | 3 | HP:0010613 | |
| HumanPheno | Abnormal feet morphology | 8.85e-04 | 26 | 38 | 3 | HP:0010611 | |
| HumanPheno | Perimembranous ventricular septal defect | 8.85e-04 | 26 | 38 | 3 | HP:0011682 | |
| Domain | Nuc_rcpt_coact | 3.22e-08 | 6 | 129 | 4 | IPR009110 | |
| Domain | ZF_PHD_2 | 4.25e-06 | 95 | 129 | 7 | PS50016 | |
| Domain | ZF_PHD_1 | 4.56e-06 | 96 | 129 | 7 | PS01359 | |
| Domain | ZF_ZZ_2 | 6.17e-06 | 18 | 129 | 4 | PS50135 | |
| Domain | ZF_ZZ_1 | 6.17e-06 | 18 | 129 | 4 | PS01357 | |
| Domain | ZZ | 6.17e-06 | 18 | 129 | 4 | PF00569 | |
| Domain | Znf_ZZ | 7.77e-06 | 19 | 129 | 4 | IPR000433 | |
| Domain | ZnF_ZZ | 7.77e-06 | 19 | 129 | 4 | SM00291 | |
| Domain | Nuc_rcpt_coact_CREBbp | 4.73e-05 | 2 | 129 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 4.73e-05 | 2 | 129 | 2 | SM00551 | |
| Domain | - | 4.73e-05 | 2 | 129 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 4.73e-05 | 2 | 129 | 2 | IPR010303 | |
| Domain | - | 4.73e-05 | 2 | 129 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 4.73e-05 | 2 | 129 | 2 | PF09030 | |
| Domain | zf-TAZ | 4.73e-05 | 2 | 129 | 2 | PF02135 | |
| Domain | ZF_TAZ | 4.73e-05 | 2 | 129 | 2 | PS50134 | |
| Domain | KAT11 | 4.73e-05 | 2 | 129 | 2 | SM01250 | |
| Domain | EIF3C_N_dom | 4.73e-05 | 2 | 129 | 2 | IPR008905 | |
| Domain | Znf_TAZ | 4.73e-05 | 2 | 129 | 2 | IPR000197 | |
| Domain | eIF-3c_N | 4.73e-05 | 2 | 129 | 2 | PF05470 | |
| Domain | KIX | 4.73e-05 | 2 | 129 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 4.73e-05 | 2 | 129 | 2 | PF08214 | |
| Domain | KIX | 4.73e-05 | 2 | 129 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 4.73e-05 | 2 | 129 | 2 | IPR031162 | |
| Domain | DUF902 | 4.73e-05 | 2 | 129 | 2 | PF06001 | |
| Domain | - | 4.73e-05 | 2 | 129 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 4.73e-05 | 2 | 129 | 2 | IPR013178 | |
| Domain | KIX_dom | 4.73e-05 | 2 | 129 | 2 | IPR003101 | |
| Domain | EIF3C | 4.73e-05 | 2 | 129 | 2 | IPR027516 | |
| Domain | CBP_P300_HAT | 4.73e-05 | 2 | 129 | 2 | PS51727 | |
| Domain | Znf_RING/FYVE/PHD | ATRX MYCBP2 PHF23 RBBP6 RSF1 TRIM31 RNF17 BRPF1 MIB1 PHF14 LONRF2 PHF10 | 8.19e-05 | 459 | 129 | 12 | IPR013083 |
| Domain | BROMODOMAIN_1 | 1.20e-04 | 37 | 129 | 4 | PS00633 | |
| Domain | Bromodomain | 1.34e-04 | 38 | 129 | 4 | PF00439 | |
| Domain | DUF1518 | 1.41e-04 | 3 | 129 | 2 | PF07469 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 1.41e-04 | 3 | 129 | 2 | IPR014920 | |
| Domain | SRC-1 | 1.41e-04 | 3 | 129 | 2 | IPR014935 | |
| Domain | Src1_rcpt_coact | 1.41e-04 | 3 | 129 | 2 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 1.41e-04 | 3 | 129 | 2 | IPR017426 | |
| Domain | - | 1.41e-04 | 3 | 129 | 2 | 4.10.630.10 | |
| Domain | DUF1518 | 1.41e-04 | 3 | 129 | 2 | IPR010011 | |
| Domain | DUF1518 | 1.41e-04 | 3 | 129 | 2 | SM01151 | |
| Domain | SRC-1 | 1.41e-04 | 3 | 129 | 2 | PF08832 | |
| Domain | Nuc_rec_co-act | 1.41e-04 | 3 | 129 | 2 | PF08815 | |
| Domain | BROMODOMAIN_2 | 1.80e-04 | 41 | 129 | 4 | PS50014 | |
| Domain | Bromodomain | 1.98e-04 | 42 | 129 | 4 | IPR001487 | |
| Domain | BROMO | 1.98e-04 | 42 | 129 | 4 | SM00297 | |
| Domain | - | 1.98e-04 | 42 | 129 | 4 | 1.20.920.10 | |
| Domain | Znf_PHD-finger | 2.18e-04 | 79 | 129 | 5 | IPR019787 | |
| Domain | - | ATRX MYCBP2 PHF23 RBBP6 RSF1 TRIM31 BRPF1 MIB1 PHF14 LONRF2 PHF10 | 2.86e-04 | 449 | 129 | 11 | 3.30.40.10 |
| Domain | PHD | 3.80e-04 | 89 | 129 | 5 | SM00249 | |
| Domain | SET_dom | 3.91e-04 | 50 | 129 | 4 | IPR001214 | |
| Domain | SET | 3.91e-04 | 50 | 129 | 4 | PS50280 | |
| Domain | Znf_PHD | 4.21e-04 | 91 | 129 | 5 | IPR001965 | |
| Domain | Znf_FYVE_PHD | 5.52e-04 | 147 | 129 | 6 | IPR011011 | |
| Domain | BRK | 6.97e-04 | 6 | 129 | 2 | SM00592 | |
| Domain | BRK_domain | 6.97e-04 | 6 | 129 | 2 | IPR006576 | |
| Domain | BRK | 6.97e-04 | 6 | 129 | 2 | PF07533 | |
| Domain | Bromodomain_CS | 7.45e-04 | 26 | 129 | 3 | IPR018359 | |
| Domain | - | 9.57e-04 | 109 | 129 | 5 | 4.10.280.10 | |
| Domain | bHLH_dom | 1.36e-03 | 118 | 129 | 5 | IPR011598 | |
| Domain | SNF2_N | 1.38e-03 | 32 | 129 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.38e-03 | 32 | 129 | 3 | PF00176 | |
| Domain | PAS | 1.38e-03 | 32 | 129 | 3 | SM00091 | |
| Domain | PAS | 1.65e-03 | 34 | 129 | 3 | PS50112 | |
| Domain | PAS | 1.65e-03 | 34 | 129 | 3 | IPR000014 | |
| Domain | PHD | 1.81e-03 | 75 | 129 | 4 | PF00628 | |
| Domain | SET | 3.93e-03 | 46 | 129 | 3 | SM00317 | |
| Domain | TUDOR | 4.08e-03 | 14 | 129 | 2 | PF00567 | |
| Domain | - | 4.69e-03 | 15 | 129 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 4.69e-03 | 15 | 129 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 4.69e-03 | 15 | 129 | 2 | IPR023394 | |
| Domain | SANT | 4.98e-03 | 50 | 129 | 3 | SM00717 | |
| Domain | RING | 5.31e-03 | 305 | 129 | 7 | SM00184 | |
| Domain | SEC7 | 5.33e-03 | 16 | 129 | 2 | PS50190 | |
| Domain | Sec7 | 5.33e-03 | 16 | 129 | 2 | SM00222 | |
| Domain | Sec7_dom | 5.33e-03 | 16 | 129 | 2 | IPR000904 | |
| Domain | PINT | 5.33e-03 | 16 | 129 | 2 | SM00088 | |
| Domain | SANT/Myb | 5.56e-03 | 52 | 129 | 3 | IPR001005 | |
| Domain | Homeobox_KN | 6.02e-03 | 17 | 129 | 2 | PF05920 | |
| Domain | Homeobox_KN_domain | 6.02e-03 | 17 | 129 | 2 | IPR008422 | |
| Domain | PCI_dom | 6.02e-03 | 17 | 129 | 2 | IPR000717 | |
| Domain | PCI | 6.02e-03 | 17 | 129 | 2 | PF01399 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 3.88e-06 | 18 | 87 | 4 | M26942 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.24e-05 | 8 | 87 | 3 | M22058 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 3.28e-05 | 30 | 87 | 4 | M207 | |
| Pathway | REACTOME_ADIPOGENESIS | 5.95e-05 | 110 | 87 | 6 | M48259 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 7.04e-05 | 70 | 87 | 5 | M938 | |
| Pathway | PID_HNF3A_PATHWAY | 1.52e-04 | 44 | 87 | 4 | M285 | |
| Pathway | REACTOME_SUMOYLATION | 1.65e-04 | 189 | 87 | 7 | M27214 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.68e-04 | 84 | 87 | 5 | M1008 | |
| Pathway | REACTOME_HEME_SIGNALING | 2.32e-04 | 49 | 87 | 4 | M41832 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 3.15e-04 | 149 | 87 | 6 | M27888 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.21e-04 | 22 | 87 | 3 | MM1370 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 3.63e-04 | 153 | 87 | 6 | M39546 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 3.72e-04 | 5 | 87 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 3.72e-04 | 5 | 87 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 3.72e-04 | 5 | 87 | 2 | M48023 | |
| Pathway | KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 3.72e-04 | 5 | 87 | 2 | M48983 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 3.72e-04 | 5 | 87 | 2 | M27228 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.18e-04 | 24 | 87 | 3 | M13404 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 5.33e-04 | 26 | 87 | 3 | M32 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 5.56e-04 | 6 | 87 | 2 | M22062 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 5.97e-04 | 27 | 87 | 3 | M26943 | |
| Pathway | REACTOME_SUMOYLATION | 6.15e-04 | 169 | 87 | 6 | MM14919 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 6.48e-04 | 64 | 87 | 4 | M200 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 6.88e-04 | 65 | 87 | 4 | M39682 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.75e-04 | 7 | 87 | 2 | MM1573 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 8.07e-04 | 118 | 87 | 5 | M27316 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.03e-03 | 8 | 87 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.03e-03 | 8 | 87 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.03e-03 | 8 | 87 | 2 | M46443 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.30e-03 | 77 | 87 | 4 | M27226 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_LOADING | 1.32e-03 | 9 | 87 | 2 | M47868 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.32e-03 | 9 | 87 | 2 | M47451 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.45e-03 | 272 | 87 | 7 | M29619 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 1.64e-03 | 38 | 87 | 3 | MM17073 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 1.64e-03 | 10 | 87 | 2 | M27945 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.79e-03 | 84 | 87 | 4 | MM14929 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 1.84e-03 | 142 | 87 | 5 | M27233 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.00e-03 | 11 | 87 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 2.00e-03 | 11 | 87 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 2.00e-03 | 11 | 87 | 2 | M26924 | |
| Pathway | WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 2.00e-03 | 11 | 87 | 2 | M42562 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 2.00e-03 | 11 | 87 | 2 | M47503 | |
| Pathway | WP_MALE_INFERTILITY | 2.02e-03 | 145 | 87 | 5 | M39856 | |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.19e-03 | 42 | 87 | 3 | M48018 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 2.19e-03 | 42 | 87 | 3 | M27172 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 2.38e-03 | 220 | 87 | 6 | M27794 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 2.39e-03 | 12 | 87 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 2.39e-03 | 12 | 87 | 2 | M27765 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 2.40e-03 | 91 | 87 | 4 | M39700 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.50e-03 | 44 | 87 | 3 | M27295 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ATRX LCORL ATAD5 SMC1A RSF1 CHD9 XPC GPATCH8 HMG20A PSIP1 BRPF1 MDC1 BRD9 MKI67 SENP6 BOP1 PHF14 CHD6 USF1 PRDM15 ZHX1 | 1.12e-14 | 608 | 129 | 21 | 36089195 |
| Pubmed | NCOA3 TCF4 ATRX PHF23 HSPA4L RBBP6 ATAD5 SMC1A NACA ETV3 CCT7 SPAG9 GPATCH8 CREBBP HMG20A ZZZ3 MDC1 BRD9 MKI67 NCOA1 MLLT1 CHD6 ASXL2 ELK4 EIF3C PRDM16 PHF10 ZHX1 EP300 | 5.44e-14 | 1429 | 129 | 29 | 35140242 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR NCOA3 ATRX MYCBP2 RBBP6 SMC1A ARFGEF2 SPAG9 XPC GPATCH8 EIF3CL PSIP1 BRPF1 MDC1 MKI67 SENP6 PHF14 TNKS1BP1 EIF3C PHF10 ZHX1 SF3B2 | 1.26e-13 | 774 | 129 | 22 | 15302935 |
| Pubmed | TPR NCOA3 ATRX PHF23 RBBP6 ATAD5 CDKN2AIP SMC1A RSF1 CHD9 CCT7 GPATCH8 CREBBP HMG20A PSIP1 MDC1 BRD9 MKI67 BOP1 PHF14 IRX2 MAGEC2 SF3B2 EP300 | 4.41e-13 | 1014 | 129 | 24 | 32416067 | |
| Pubmed | TCF4 TBX3 CREBBP MEIS1 ZZZ3 PER2 BRPF1 BRD9 MKI67 NCOA1 MACF1 BOP1 PHF14 ELK4 USF1 IRX2 PRDM16 PHF10 ABTB2 | 1.89e-11 | 709 | 129 | 19 | 22988430 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 BDP1 CPAMD8 CDS1 ATRX LUC7L3 MYCBP2 STXBP5L CHD9 DGKH BTBD9 COG3 CREBBP THAP4 INF2 ANKRD11 MAST1 MACF1 ASTN2 PHF14 FGF13 CHD6 ELK4 PRDM15 EP300 HTT | 3.78e-11 | 1489 | 129 | 26 | 28611215 |
| Pubmed | ATRX MYCBP2 SMC1A IQSEC2 ARFGEF2 CHD9 CCT7 XPC DZIP1 CREBBP HMG20A THAP4 NMT2 MIB1 SENP6 MAST1 MACF1 ASTN2 CHD6 METTL8 EIF3C SF3B2 EP300 JPH3 | 6.14e-11 | 1285 | 129 | 24 | 35914814 | |
| Pubmed | NCOA3 TCF4 TBX3 PHF23 LCORL ETV3 DZIP1 BTBD9 MEIS1 HMG20A THAP4 BRPF1 NCOA1 PHF14 USF1 PRDM16 PHF10 SF3B2 ABTB2 | 1.72e-10 | 808 | 129 | 19 | 20412781 | |
| Pubmed | ATRX RBBP6 ATAD5 CDKN2AIP NACA ACBD5 CCT7 XPC GPATCH8 CYFIP2 HMG20A CRACD UBXN4 NMT2 MDC1 BRD9 ANKRD11 PALM3 MLLT1 MACF1 BOP1 PHF14 CHD6 EIF3C ZHX1 | 2.42e-10 | 1497 | 129 | 25 | 31527615 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR ATRX LUC7L3 RBBP6 ATAD5 CDKN2AIP SMC1A RSF1 CYFIP2 HMG20A ZZZ3 PSIP1 MDC1 BRD9 MKI67 ANKRD11 SENP6 MLLT1 PHF14 SF3B2 | 4.04e-10 | 954 | 129 | 20 | 36373674 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA3 TBX3 CREBBP ZZZ3 MDC1 BRD9 MKI67 NCOA1 ASXL2 PRDM16 PHF10 ZHX1 EP300 | 7.43e-10 | 351 | 129 | 13 | 38297188 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | TBX3 ATRX MYCBP2 RBBP6 SMC1A RNF17 CYFIP2 CELSR2 MDC1 MIB1 MKI67 MACF1 EP300 | 9.43e-10 | 358 | 129 | 13 | 32460013 |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 1.09e-09 | 85 | 129 | 8 | 16051665 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR ATRX RBBP6 ATAD5 CDKN2AIP NACA RSF1 CCT7 SPAG9 RTN1 CRACD SIRT2 PSIP1 MKI67 SENP6 MACF1 TNKS1BP1 EIF3C SF3B2 | 1.89e-09 | 934 | 129 | 19 | 33916271 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TBX3 ATRX LUC7L3 RBBP6 ATAD5 SMC1A XPC GPATCH8 HMG20A THAP4 ZZZ3 PSIP1 MDC1 MKI67 ANKRD11 MLLT1 PHF14 CHD6 ASXL2 USF1 SF3B2 EP300 | 2.42e-09 | 1294 | 129 | 22 | 30804502 |
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 2.69e-09 | 6 | 129 | 4 | 11076796 | |
| Pubmed | 7.98e-09 | 157 | 129 | 9 | 30186101 | ||
| Pubmed | 1.25e-08 | 8 | 129 | 4 | 17475621 | ||
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 4.99e-08 | 3 | 129 | 3 | 11823864 | |
| Pubmed | 4.99e-08 | 3 | 129 | 3 | 17410209 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TPR CDKN2AIP SMC1A NACA HJURP CCT7 SPAG9 XPC EIF3CL PER2 INF2 MYPN MIB1 MKI67 TNKS1BP1 ASXL2 EIF3C PHF10 SF3B2 | 5.63e-08 | 1155 | 129 | 19 | 20360068 |
| Pubmed | GAP43 MYCBP2 HSPA4L STXBP5L RTN1 EIF3CL MACF1 TNKS1BP1 EIF3C HTT JPH3 | 7.77e-08 | 347 | 129 | 11 | 17114649 | |
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 8.74e-08 | 12 | 129 | 4 | 14645221 | |
| Pubmed | 1.21e-07 | 103 | 129 | 7 | 10574462 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR TCF4 CMTR1 PHF23 SMC1A SPAG9 CREBBP MEIS1 CYFIP2 CRACD PRDM10 PSIP1 ASXL2 PRDM15 SF3B2 EP300 | 1.28e-07 | 857 | 129 | 16 | 25609649 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.46e-07 | 220 | 129 | 9 | 35785414 | |
| Pubmed | TBX3 RBBP6 ATAD5 RSF1 CHD9 XPC CREBBP HMG20A ZZZ3 BRPF1 BRD9 TCF25 MLLT1 MACF1 IRX2 PRDM16 PHF10 EP300 | 1.74e-07 | 1116 | 129 | 18 | 31753913 | |
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 10551785 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 16227615 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 12208951 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 11463834 | ||
| Pubmed | CBP/p300 interact with and function as transcriptional coactivators of BRCA1. | 1.99e-07 | 4 | 129 | 3 | 10655477 | |
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 11113179 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 11701890 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 33589584 | ||
| Pubmed | 1.99e-07 | 4 | 129 | 3 | 15449938 | ||
| Pubmed | 2.46e-07 | 234 | 129 | 9 | 36243803 | ||
| Pubmed | DENND2A GAP43 HSPA4L IQSEC2 ARFGEF2 CCT7 RTN1 CYFIP2 EIF3CL CRACD SIRT2 INF2 NMT2 VCAN PRKAA1 MAST1 MACF1 TNKS1BP1 FGF13 EIF3C | 3.34e-07 | 1431 | 129 | 20 | 37142655 | |
| Pubmed | 4.14e-07 | 17 | 129 | 4 | 19183483 | ||
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 12714702 | ||
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 14722092 | ||
| Pubmed | SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. | 4.96e-07 | 5 | 129 | 3 | 9812974 | |
| Pubmed | Transcription factor-specific requirements for coactivators and their acetyltransferase functions. | 4.96e-07 | 5 | 129 | 3 | 9445475 | |
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 19270680 | ||
| Pubmed | 4.96e-07 | 5 | 129 | 3 | 10224118 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPR NCOA3 LUC7L3 RBBP6 SMC1A NACA CCT7 EIF3CL PSIP1 MDC1 BRD9 MKI67 TCF25 BOP1 EIF3C SF3B2 | 5.00e-07 | 949 | 129 | 16 | 36574265 |
| Pubmed | NCOA3 LUC7L3 ARFGEF2 GPATCH8 RNF17 CREBBP EIF3CL MKI67 MACF1 EIF3C | 5.37e-07 | 335 | 129 | 10 | 15741177 | |
| Pubmed | NCOA3 DENND2A RBBP6 NACA RSF1 ETV3 GPATCH8 CREBBP PSIP1 USF1 EP300 | 5.84e-07 | 425 | 129 | 11 | 24999758 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | CMTR1 ATRX ATAD5 RSF1 CHD9 EIF3CL HMG20A PSIP1 MDC1 BRD9 MKI67 BOP1 | 7.66e-07 | 533 | 129 | 12 | 30554943 |
| Pubmed | 8.36e-07 | 20 | 129 | 4 | 11877444 | ||
| Pubmed | TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | 8.88e-07 | 138 | 129 | 7 | 37506885 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | TCF4 LCORL CCT7 SPAG9 CHGB THAP4 ZZZ3 PSIP1 INF2 NMT2 MKI67 TCF25 BOP1 OSBP2 EIF3C ZHX1 SF3B2 | 9.58e-07 | 1124 | 129 | 17 | 21900206 |
| Pubmed | 9.89e-07 | 6 | 129 | 3 | 10777539 | ||
| Pubmed | 9.89e-07 | 6 | 129 | 3 | 16923966 | ||
| Pubmed | 9.89e-07 | 6 | 129 | 3 | 10497212 | ||
| Pubmed | CBP-mediated FOXO-1 acetylation inhibits pancreatic tumor growth by targeting SirT. | 9.89e-07 | 6 | 129 | 3 | 24419059 | |
| Pubmed | 9.89e-07 | 6 | 129 | 3 | 26123998 | ||
| Pubmed | 9.89e-07 | 6 | 129 | 3 | 17970752 | ||
| Pubmed | Role of CBP in regulating HIF-1-mediated activation of transcription. | 9.89e-07 | 6 | 129 | 3 | 15615775 | |
| Pubmed | 9.89e-07 | 6 | 129 | 3 | 10973497 | ||
| Pubmed | Roles of coactivators in hypoxic induction of the erythropoietin gene. | 9.89e-07 | 6 | 129 | 3 | 20368990 | |
| Pubmed | 1.03e-06 | 21 | 129 | 4 | 19596656 | ||
| Pubmed | TPR GAP43 MYCBP2 STXBP5L IQSEC2 NACA ACBD5 CCT7 RTN1 EIF3CL UBXN4 CELSR2 SNX25 TCF25 MACF1 EIF3C JPH3 | 1.15e-06 | 1139 | 129 | 17 | 36417873 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.43e-06 | 289 | 129 | 9 | 23752268 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | NCOA3 TCF4 TBX3 LCORL ETV3 MEIS1 THAP4 CTCFL ZZZ3 NCOA1 MLLT1 ELK4 USF1 IRX2 ZHX1 | 1.50e-06 | 908 | 129 | 15 | 19274049 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | PAG1 ATRX HSPA4L GPATCH8 CREBBP CYFIP2 EIF3CL CYB5B NMT2 PRKAA1 MLLT1 BOP1 EIF3C MAP3K13 EP300 | 1.54e-06 | 910 | 129 | 15 | 36736316 |
| Pubmed | 1.73e-06 | 7 | 129 | 3 | 21195347 | ||
| Pubmed | BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells. | 1.73e-06 | 7 | 129 | 3 | 16860316 | |
| Pubmed | The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. | 1.73e-06 | 7 | 129 | 3 | 9192892 | |
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 1.73e-06 | 7 | 129 | 3 | 9590696 | |
| Pubmed | 1.73e-06 | 7 | 129 | 3 | 12709428 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 2.11e-06 | 157 | 129 | 7 | 30686591 | |
| Pubmed | 2.11e-06 | 225 | 129 | 8 | 12168954 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.31e-06 | 394 | 129 | 10 | 27248496 | |
| Pubmed | 2.33e-06 | 57 | 129 | 5 | 18022353 | ||
| Pubmed | PRUNE2 CMTR1 SMC1A SPAG9 BTBD9 AMIGO1 SHROOM4 MACF1 ASTN2 PHF14 PRDM16 | 2.46e-06 | 493 | 129 | 11 | 15368895 | |
| Pubmed | Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase. | 2.75e-06 | 8 | 129 | 3 | 11971985 | |
| Pubmed | 2.75e-06 | 8 | 129 | 3 | 12082103 | ||
| Pubmed | 2.75e-06 | 8 | 129 | 3 | 8616895 | ||
| Pubmed | 2.75e-06 | 8 | 129 | 3 | 10490106 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | TPR LUC7L3 LCORL ATAD5 SMC1A PSIP1 MDC1 MKI67 BOP1 PHF14 EIF3C SF3B2 | 2.84e-06 | 605 | 129 | 12 | 28977666 |
| Pubmed | SETD1B GPATCH8 FHIP2A CRACD PER2 TCF25 MAST1 MACF1 CHD6 ASXL2 | 3.08e-06 | 407 | 129 | 10 | 12693553 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CMTR1 MYCBP2 DOCK11 ATAD5 XPC CYFIP2 BRPF1 PRKAA1 BRD9 MKI67 MACF1 BOP1 PHF10 | 3.19e-06 | 724 | 129 | 13 | 36232890 |
| Pubmed | 3.45e-06 | 28 | 129 | 4 | 24880616 | ||
| Pubmed | NCOA3 MYCBP2 LCORL CDKN2AIP SMC1A CHD9 CCT7 CREBBP THAP4 PSIP1 BRD9 MKI67 NCOA1 ASXL2 USF1 EP300 | 3.50e-06 | 1103 | 129 | 16 | 34189442 | |
| Pubmed | 4.12e-06 | 9 | 129 | 3 | 9346901 | ||
| Pubmed | Tcf4 is required for correct brain development during embryogenesis. | 4.12e-06 | 9 | 129 | 3 | 32474139 | |
| Pubmed | 4.12e-06 | 9 | 129 | 3 | 15184363 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 5.50e-06 | 341 | 129 | 9 | 32971831 | |
| Pubmed | Human ALKBH4 interacts with proteins associated with transcription. | 5.87e-06 | 10 | 129 | 3 | 23145062 | |
| Pubmed | 5.87e-06 | 10 | 129 | 3 | 11163245 | ||
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 5.87e-06 | 10 | 129 | 3 | 30595551 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETD1B ATRX MYCBP2 DOCK11 HSPA4L CCT7 GPATCH8 MDC1 MKI67 BOP1 | 6.11e-06 | 440 | 129 | 10 | 34244565 |
| Pubmed | 7.45e-06 | 72 | 129 | 5 | 31248990 | ||
| Pubmed | 8.05e-06 | 11 | 129 | 3 | 10454579 | ||
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 8.05e-06 | 11 | 129 | 3 | 15681609 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 8.28e-06 | 271 | 129 | 8 | 32433965 | |
| Pubmed | NCOA3 ATRX RBBP6 SMC1A RSF1 HMG20A PSIP1 PHF14 TNKS1BP1 CHD6 | 1.06e-05 | 469 | 129 | 10 | 27634302 | |
| Pubmed | DMRT1 promotes oogenesis by transcriptional activation of Stra8 in the mammalian fetal ovary. | 1.07e-05 | 12 | 129 | 3 | 21621532 | |
| Pubmed | ISL1 regulates lung branching morphogenesis via Shh signaling pathway. | 1.07e-05 | 12 | 129 | 3 | 37442233 | |
| Interaction | H3-3A interactions | SETD1B ATRX LCORL ATAD5 SMC1A RSF1 CHD9 SPAG9 XPC GPATCH8 CREBBP HMG20A PSIP1 BRPF1 MDC1 BRD9 MKI67 SENP6 PHF14 ELK4 USF1 PRDM15 ZHX1 SF3B2 EP300 | 9.74e-12 | 749 | 129 | 25 | int:H3-3A |
| Interaction | CSNK2A1 interactions | BDP1 ATRX GAP43 ATAD5 NACA RSF1 CREBBP EIF3CL HMG20A PSIP1 INF2 NMT2 MDC1 BRD9 ANKRD11 MAST1 MLLT1 MACF1 BOP1 TNKS1BP1 ASXL2 EIF3C MAP3K13 PRDM16 ZHX1 SF3B2 EP300 HTT | 1.02e-11 | 956 | 129 | 28 | int:CSNK2A1 |
| Interaction | NUP43 interactions | SETD1B LUC7L3 RBBP6 CDKN2AIP SMC1A RSF1 MUC19 CHD9 CCT7 XPC GPATCH8 ZZZ3 PSIP1 MDC1 MKI67 ANKRD11 SENP6 BOP1 CHD6 ASXL2 ZHX1 | 4.83e-10 | 625 | 129 | 21 | int:NUP43 |
| Interaction | H3C1 interactions | TPR SETD1B ATRX ATAD5 SMC1A NACA RSF1 SPAG9 XPC CREBBP CTCFL SIRT2 PSIP1 BRPF1 MDC1 MKI67 SENP6 MLLT1 ELK4 EIF3C USF1 PRDM16 SF3B2 EP300 | 2.55e-09 | 901 | 129 | 24 | int:H3C1 |
| Interaction | FEV interactions | NCOA3 ATRX SMC1A GPATCH8 CREBBP HMG20A CHD6 ASXL2 PHF10 ZHX1 EP300 | 7.80e-08 | 203 | 129 | 11 | int:FEV |
| Interaction | CENPA interactions | ATRX ATAD5 HJURP RSF1 XPC HMG20A PSIP1 BRPF1 BRD9 ANKRD11 SENP6 MLLT1 PHF14 CHD6 | 1.41e-07 | 377 | 129 | 14 | int:CENPA |
| Interaction | XRCC6 interactions | TPR TCF4 TBX3 CMTR1 ATRX RBBP6 CDKN2AIP SMC1A TRIM31 XPC CREBBP CYREN PSIP1 MDC1 MKI67 ASXL2 USF1 PRDM16 SF3B2 EP300 HTT | 4.41e-07 | 928 | 129 | 21 | int:XRCC6 |
| Interaction | H3C3 interactions | ATRX LCORL ATAD5 SMC1A RSF1 XPC HMG20A BRPF1 MDC1 BRD9 MKI67 BOP1 PHF14 CHD6 PRDM15 | 6.64e-07 | 495 | 129 | 15 | int:H3C3 |
| Interaction | CBX3 interactions | ATRX RBBP6 ATAD5 RSF1 CHD9 XPC PRDM10 PSIP1 MDC1 MKI67 SENP6 MACF1 TNKS1BP1 ASXL2 PRDM16 PHF10 EP300 | 8.12e-07 | 646 | 129 | 17 | int:CBX3 |
| Interaction | H2BC8 interactions | CMTR1 ATRX ATAD5 RSF1 XPC HMG20A PSIP1 BRPF1 MDC1 MKI67 SENP6 BOP1 PHF14 CHD6 PRDM15 PHF10 | 8.69e-07 | 576 | 129 | 16 | int:H2BC8 |
| Interaction | PARP1 interactions | TCF4 CMTR1 MYCBP2 ATAD5 CDKN2AIP SMC1A RSF1 XPC CREBBP HMG20A SIRT2 PSIP1 PRKAA1 MKI67 SENP6 MLLT1 PHF14 CHD6 ASXL2 EIF3C USF1 PRDM16 PHF10 EP300 | 2.85e-06 | 1316 | 129 | 24 | int:PARP1 |
| Interaction | HMGA1 interactions | CMTR1 RSF1 XPC CREBBP HMG20A ATXN3L PSIP1 PER2 MDC1 PHF14 PRDM16 PHF10 HTT | 2.99e-06 | 419 | 129 | 13 | int:HMGA1 |
| Interaction | CSNK2A2 interactions | ATRX NACA XPC CREBBP EIF3CL NMT2 BRPF1 MKI67 PALM3 MAST1 BOP1 PHF14 EIF3C PRDM16 SF3B2 EP300 HTT | 3.40e-06 | 718 | 129 | 17 | int:CSNK2A2 |
| Interaction | NAA40 interactions | TPR ATRX RBBP6 ATAD5 CDKN2AIP NACA RSF1 CCT7 SPAG9 XPC RTN1 CRACD SIRT2 PSIP1 MKI67 SENP6 MACF1 TNKS1BP1 EIF3C SF3B2 | 4.02e-06 | 978 | 129 | 20 | int:NAA40 |
| Interaction | H2AC4 interactions | ATRX HSPA4L ATAD5 CHD9 XPC CREBBP HMG20A PRDM10 SIRT2 NMT2 BOP1 PHF14 SF3B2 EP300 | 4.61e-06 | 506 | 129 | 14 | int:H2AC4 |
| Interaction | RBBP7 interactions | LUC7L3 MYCBP2 PHF23 SMC1A HJURP TRIM31 CCT7 SPAG9 CREBBP HMG20A USF1 PRDM16 ZHX1 EP300 | 4.71e-06 | 507 | 129 | 14 | int:RBBP7 |
| Interaction | EWSR1 interactions | PRUNE2 NCOA3 DENND2A TBX3 MYCBP2 RBBP6 NACA RSF1 TRIM31 ETV3 GPATCH8 CREBBP SIRT2 PSIP1 MDC1 MKI67 USF1 SF3B2 EP300 | 5.03e-06 | 906 | 129 | 19 | int:EWSR1 |
| Interaction | TLE3 interactions | NCOA3 TCF4 TBX3 RBBP6 GPATCH8 CREBBP SENP6 NCOA1 TNKS1BP1 CHD6 ASXL2 EP300 | 5.50e-06 | 376 | 129 | 12 | int:TLE3 |
| Interaction | SMC5 interactions | TPR ATRX LUC7L3 RBBP6 ATAD5 CDKN2AIP SMC1A RSF1 CYFIP2 HMG20A ZZZ3 PSIP1 MDC1 BRD9 MKI67 ANKRD11 SENP6 MLLT1 PHF14 SF3B2 | 5.61e-06 | 1000 | 129 | 20 | int:SMC5 |
| Interaction | TRIM24 interactions | TCF4 SMC1A RSF1 XPC CREBBP BRPF1 NCOA1 MLLT1 TNKS1BP1 SF3B2 EP300 ABTB2 | 9.77e-06 | 398 | 129 | 12 | int:TRIM24 |
| Interaction | HNF4A interactions | 1.12e-05 | 275 | 129 | 10 | int:HNF4A | |
| Interaction | SIRT6 interactions | SETD1B ATRX MYCBP2 DOCK11 HSPA4L SMC1A CCT7 XPC GPATCH8 CREBBP CELSR2 MDC1 MKI67 BOP1 EP300 | 1.21e-05 | 628 | 129 | 15 | int:SIRT6 |
| Interaction | NUCKS1 interactions | 1.23e-05 | 220 | 129 | 9 | int:NUCKS1 | |
| Interaction | ETS1 interactions | 1.29e-05 | 121 | 129 | 7 | int:ETS1 | |
| Interaction | SUMO1 interactions | 1.62e-05 | 287 | 129 | 10 | int:SUMO1 | |
| Interaction | DAXX interactions | TCF4 SETD1B ATRX CHD9 CREBBP PRDM10 MKI67 MACF1 PHF14 SF3B2 EP300 | 1.72e-05 | 353 | 129 | 11 | int:DAXX |
| Interaction | HDAC1 interactions | TPR TBX3 ATRX LUC7L3 MYCBP2 PHF23 SMC1A CCT7 SPAG9 CREBBP HMG20A ZZZ3 MKI67 PHF14 TNKS1BP1 EIF3C PRDM16 ZHX1 SF3B2 EP300 | 2.49e-05 | 1108 | 129 | 20 | int:HDAC1 |
| Interaction | PTEN interactions | TPR NCOA3 ATRX HSPA4L RBBP6 NACA XPC CHGB CREBBP INF2 MDC1 MKI67 SCN10A ANKRD11 TCF25 MAST1 BOP1 OSBP2 | 2.64e-05 | 929 | 129 | 18 | int:PTEN |
| Interaction | SP7 interactions | NCOA3 RBBP6 SMC1A GPATCH8 CREBBP HMG20A NCOA1 MLLT1 PHF10 EP300 | 2.66e-05 | 304 | 129 | 10 | int:SP7 |
| Interaction | XRCC5 interactions | TPR NCOA3 TCF4 TBX3 CMTR1 ATRX XPC CYREN BRPF1 MDC1 USF1 PRDM16 EP300 | 2.70e-05 | 515 | 129 | 13 | int:XRCC5 |
| Interaction | H2AX interactions | ATRX SMC1A NACA RSF1 XPC GPATCH8 HMG20A PSIP1 MDC1 MKI67 MLLT1 PHF14 SF3B2 EP300 | 2.73e-05 | 593 | 129 | 14 | int:H2AX |
| Interaction | CHD3 interactions | TPR LUC7L3 ATAD5 SMC1A HJURP CREBBP PSIP1 MKI67 PHF14 FGF13 CHD6 EIF3C ZHX1 SF3B2 EP300 HTT | 2.73e-05 | 757 | 129 | 16 | int:CHD3 |
| Interaction | ZNF330 interactions | ATAD5 RSF1 XPC GPATCH8 HMG20A PSIP1 BRPF1 ANKRD11 SENP6 MLLT1 PHF14 PRDM15 | 3.01e-05 | 446 | 129 | 12 | int:ZNF330 |
| Interaction | CDC5L interactions | TPR CMTR1 RBBP6 CDKN2AIP SMC1A TRIM31 CCT7 RNF17 MDC1 SENP6 MAST1 MACF1 TNKS1BP1 MAP3K13 PRDM16 SF3B2 EP300 | 3.27e-05 | 855 | 129 | 17 | int:CDC5L |
| Interaction | ASF1A interactions | 3.28e-05 | 249 | 129 | 9 | int:ASF1A | |
| Interaction | CRX interactions | 3.83e-05 | 254 | 129 | 9 | int:CRX | |
| Interaction | H2BC21 interactions | ATRX ATAD5 RSF1 XPC CREBBP HMG20A ZZZ3 PSIP1 BRPF1 MDC1 MKI67 MLLT1 PHF14 PHF10 EP300 | 3.98e-05 | 696 | 129 | 15 | int:H2BC21 |
| Interaction | KAT2B interactions | 4.07e-05 | 256 | 129 | 9 | int:KAT2B | |
| Interaction | BRCA1 interactions | TPR NCOA3 HSPA4L CDKN2AIP SMC1A NACA ARFGEF2 CHD9 CCT7 SPAG9 CREBBP CTCFL ZZZ3 MDC1 BRD9 MKI67 NCOA1 ELK4 ZHX1 SF3B2 EP300 | 4.34e-05 | 1249 | 129 | 21 | int:BRCA1 |
| Interaction | HOXA10 interactions | 4.80e-05 | 62 | 129 | 5 | int:HOXA10 | |
| Interaction | CSNK2B interactions | ATRX ARFGEF2 XPC CREBBP PER2 NMT2 BRPF1 ANKRD11 MAST1 EIF3C PRDM16 ZHX1 SF3B2 EP300 | 4.83e-05 | 625 | 129 | 14 | int:CSNK2B |
| Interaction | NEUROD1 interactions | 5.01e-05 | 32 | 129 | 4 | int:NEUROD1 | |
| Interaction | HAUS3 interactions | 5.27e-05 | 103 | 129 | 6 | int:HAUS3 | |
| Interaction | ASH2L interactions | 5.32e-05 | 265 | 129 | 9 | int:ASH2L | |
| Interaction | TERF2IP interactions | CMTR1 RBBP6 ATAD5 RSF1 CREBBP ZZZ3 PSIP1 MDC1 MKI67 ANKRD11 SENP6 PHF10 SF3B2 | 5.50e-05 | 552 | 129 | 13 | int:TERF2IP |
| Interaction | H4C16 interactions | 5.60e-05 | 152 | 129 | 7 | int:H4C16 | |
| Interaction | SNRNP40 interactions | LUC7L3 RBBP6 ATAD5 CDKN2AIP RSF1 XPC GPATCH8 HMG20A PRDM10 MDC1 MKI67 SENP6 BOP1 PHF10 | 5.92e-05 | 637 | 129 | 14 | int:SNRNP40 |
| Interaction | ALKBH4 interactions | 6.40e-05 | 34 | 129 | 4 | int:ALKBH4 | |
| Interaction | FOCAD interactions | 6.99e-05 | 67 | 129 | 5 | int:FOCAD | |
| Interaction | ELAVL3 interactions | 7.19e-05 | 35 | 129 | 4 | int:ELAVL3 | |
| Interaction | ANKRD11 interactions | 7.45e-05 | 159 | 129 | 7 | int:ANKRD11 | |
| Interaction | RBBP4 interactions | PHF23 SMC1A HJURP SPAG9 CREBBP HMG20A MIB1 PHF14 ASXL2 USF1 PRDM16 ZHX1 EP300 | 8.02e-05 | 573 | 129 | 13 | int:RBBP4 |
| Interaction | HOXB2 interactions | 8.05e-05 | 36 | 129 | 4 | int:HOXB2 | |
| Interaction | EIF3H interactions | 8.58e-05 | 282 | 129 | 9 | int:EIF3H | |
| Interaction | USP7 interactions | TPR TBX3 ATRX LUC7L3 GAP43 SKIDA1 TRIM31 XPC CREBBP SHROOM4 PSIP1 SNX25 BRPF1 MDC1 MYPN TCF25 MACF1 LONRF2 PRDM16 SF3B2 EP300 | 8.87e-05 | 1313 | 129 | 21 | int:USP7 |
| Interaction | RNPS1 interactions | LUC7L3 RBBP6 XPC GPATCH8 BTBD9 HMG20A PRDM10 BRD9 MKI67 PHF14 EP300 | 9.23e-05 | 425 | 129 | 11 | int:RNPS1 |
| Interaction | SMARCE1 interactions | 9.81e-05 | 287 | 129 | 9 | int:SMARCE1 | |
| Interaction | FOXK2 interactions | 1.02e-04 | 225 | 129 | 8 | int:FOXK2 | |
| Interaction | CHD4 interactions | TPR LUC7L3 LCORL RBBP6 SMC1A RSF1 SPAG9 GPATCH8 PSIP1 MDC1 MKI67 BOP1 PHF14 EIF3C PRDM16 SF3B2 EP300 | 1.02e-04 | 938 | 129 | 17 | int:CHD4 |
| Interaction | RORA interactions | 1.11e-04 | 39 | 129 | 4 | int:RORA | |
| Interaction | HDAC2 interactions | TBX3 MYCBP2 CDKN2AIP SMC1A SPAG9 CREBBP HMG20A INF2 PRKAA1 MKI67 TCF25 PHF14 TNKS1BP1 PRDM16 ZHX1 EP300 | 1.32e-04 | 865 | 129 | 16 | int:HDAC2 |
| Interaction | DNTT interactions | 1.35e-04 | 16 | 129 | 3 | int:DNTT | |
| Interaction | SRSF4 interactions | 1.37e-04 | 300 | 129 | 9 | int:SRSF4 | |
| Interaction | RAD50 interactions | 1.40e-04 | 371 | 129 | 10 | int:RAD50 | |
| Interaction | TEAD1 interactions | 1.40e-04 | 176 | 129 | 7 | int:TEAD1 | |
| Interaction | PRPF40A interactions | TPR TRIM31 ARFGEF2 CCT7 DZIP1 CYFIP2 ASXL2 ZHX1 SF3B2 EP300 HTT | 1.41e-04 | 446 | 129 | 11 | int:PRPF40A |
| Interaction | PRC1 interactions | BDP1 TPR ATRX LUC7L3 HSPA4L RBBP6 NACA RSF1 PSIP1 INF2 MDC1 BRD9 MKI67 PKIA BOP1 PHF14 SF3B2 | 1.59e-04 | 973 | 129 | 17 | int:PRC1 |
| Interaction | HNF1A interactions | 1.63e-04 | 80 | 129 | 5 | int:HNF1A | |
| Interaction | PPARG interactions | 1.63e-04 | 307 | 129 | 9 | int:PPARG | |
| Interaction | EYA4 interactions | 1.73e-04 | 243 | 129 | 8 | int:EYA4 | |
| Interaction | SOX7 interactions | 1.83e-04 | 82 | 129 | 5 | int:SOX7 | |
| Interaction | PPARGC1A interactions | 1.83e-04 | 82 | 129 | 5 | int:PPARGC1A | |
| Interaction | SMARCC1 interactions | 1.85e-04 | 384 | 129 | 10 | int:SMARCC1 | |
| Interaction | EEF1G interactions | CMTR1 NACA TRIM31 CHD9 CCT7 HMG20A BRD9 PHF14 ASXL2 EP300 HTT | 1.95e-04 | 463 | 129 | 11 | int:EEF1G |
| Interaction | THRB interactions | 1.97e-04 | 186 | 129 | 7 | int:THRB | |
| Interaction | ZNF106 interactions | 2.05e-04 | 84 | 129 | 5 | int:ZNF106 | |
| Interaction | DOT1L interactions | TPR TCF4 ATRX LUC7L3 RBBP6 SMC1A XPC PSIP1 BRPF1 MDC1 MKI67 MLLT1 BOP1 EIF3C SF3B2 | 2.05e-04 | 807 | 129 | 15 | int:DOT1L |
| Interaction | NUMA1 interactions | HSPA4L SMC1A RSF1 PSIP1 BRPF1 MDC1 MKI67 MACF1 PHF14 PHF10 EP300 | 2.18e-04 | 469 | 129 | 11 | int:NUMA1 |
| Interaction | H2AC20 interactions | 2.22e-04 | 320 | 129 | 9 | int:H2AC20 | |
| Interaction | TBP interactions | 2.28e-04 | 253 | 129 | 8 | int:TBP | |
| Interaction | WDR5 interactions | TPR SETD1B CDKN2AIP NACA CCT7 SPAG9 CREBBP ZZZ3 PSIP1 BRD9 MLLT1 MACF1 BOP1 ASXL2 EIF3C USF1 SF3B2 EP300 | 2.29e-04 | 1101 | 129 | 18 | int:WDR5 |
| Interaction | CDX2 interactions | 2.29e-04 | 86 | 129 | 5 | int:CDX2 | |
| Interaction | NEUROG1 interactions | 2.30e-04 | 19 | 129 | 3 | int:NEUROG1 | |
| Interaction | SETD2 interactions | 2.34e-04 | 135 | 129 | 6 | int:SETD2 | |
| Interaction | GSC interactions | 2.41e-04 | 87 | 129 | 5 | int:GSC | |
| Interaction | DDX23 interactions | CMTR1 LUC7L3 RBBP6 SPAG9 XPC GPATCH8 BRPF1 ANKRD11 MLLT1 BOP1 EP300 | 2.66e-04 | 480 | 129 | 11 | int:DDX23 |
| Interaction | YWHAZ interactions | BDP1 MYCBP2 DOCK11 SMC1A IQSEC2 HJURP RSF1 DZIP1 CYFIP2 CRACD PER2 MDC1 PRKAA1 TCF25 MAST1 MACF1 ASXL2 SF3B2 EP300 HTT | 2.70e-04 | 1319 | 129 | 20 | int:YWHAZ |
| Interaction | H2AC19 interactions | 2.94e-04 | 50 | 129 | 4 | int:H2AC19 | |
| Interaction | ATM interactions | 2.97e-04 | 333 | 129 | 9 | int:ATM | |
| Interaction | POLR1G interactions | CMTR1 ATAD5 SMC1A RSF1 CHD9 XPC BRPF1 ANKRD11 MLLT1 BOP1 PHF14 | 3.11e-04 | 489 | 129 | 11 | int:POLR1G |
| Interaction | SLX4 interactions | CMTR1 ATRX SMC1A NACA CHD9 CREBBP ZZZ3 MDC1 MKI67 SENP6 MLLT1 SF3B2 | 3.12e-04 | 572 | 129 | 12 | int:SLX4 |
| Interaction | SOX10 interactions | 3.13e-04 | 92 | 129 | 5 | int:SOX10 | |
| Interaction | PPARA interactions | 3.13e-04 | 92 | 129 | 5 | int:PPARA | |
| Interaction | HOXB4 interactions | 3.13e-04 | 21 | 129 | 3 | int:HOXB4 | |
| Interaction | EIF3B interactions | 3.25e-04 | 337 | 129 | 9 | int:EIF3B | |
| Interaction | CEBPB interactions | TPR LUC7L3 CDKN2AIP SMC1A NACA RSF1 CCT7 XPC GPATCH8 COG3 CREBBP HMG20A SIRT2 PSIP1 MKI67 MLLT1 PHF14 ASXL2 EIF3C SF3B2 EP300 | 3.25e-04 | 1443 | 129 | 21 | int:CEBPB |
| Interaction | NCOA6 interactions | 3.44e-04 | 145 | 129 | 6 | int:NCOA6 | |
| Interaction | NCOA1 interactions | 3.57e-04 | 146 | 129 | 6 | int:NCOA1 | |
| Interaction | SON interactions | 3.89e-04 | 208 | 129 | 7 | int:SON | |
| Interaction | SYT2 interactions | 4.12e-04 | 150 | 129 | 6 | int:SYT2 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.19e-06 | 17 | 88 | 4 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.52e-06 | 18 | 88 | 4 | 91 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 7.21e-05 | 17 | 88 | 3 | 1197 | |
| GeneFamily | PHD finger proteins | 7.73e-05 | 90 | 88 | 5 | 88 | |
| GeneFamily | Basic helix-loop-helix proteins | 2.04e-03 | 110 | 88 | 4 | 420 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.19e-03 | 53 | 88 | 3 | 532 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 5.08e-03 | 22 | 88 | 2 | 579 | |
| GeneFamily | PWWP domain containing | 5.08e-03 | 22 | 88 | 2 | 1147 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.40e-11 | 90 | 129 | 10 | M39250 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | PRUNE2 LUC7L3 XPC DZIP1 CREBBP SHROOM4 BRD9 ANKRD11 TCF25 ASTN2 PHF14 CHD6 MAP3K13 | 1.54e-07 | 417 | 129 | 13 | M39224 |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN | 6.27e-07 | 198 | 129 | 9 | M6128 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 TPR NCOA3 PAG1 ATRX MYCBP2 DOCK11 RBBP6 RSF1 GMIP GPATCH8 FHIP2A CREBBP CYFIP2 UBXN4 PSIP1 ANKRD11 SENP6 NCOA1 MACF1 ASXL2 ELK4 EP300 | 9.86e-07 | 1492 | 129 | 23 | M40023 |
| Coexpression | GABRIELY_MIR21_TARGETS | 1.76e-06 | 289 | 129 | 10 | M2196 | |
| Coexpression | GSE27896_HDAC6_KO_VS_WT_TREG_UP | 2.69e-06 | 176 | 129 | 8 | M8248 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 9.21e-06 | 208 | 129 | 8 | MM581 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | NCOA3 HSPA4L CDKN2AIP RSF1 ARFGEF2 SPAG9 GPATCH8 CREBBP PRDM10 PER2 SENP6 NCOA1 ELK4 EP300 ABTB2 | 1.33e-05 | 822 | 129 | 15 | M6782 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.85e-05 | 300 | 129 | 9 | M8702 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 1.88e-05 | 166 | 129 | 7 | M6826 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.17e-05 | 180 | 129 | 7 | M8239 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_INTERMEDIATE_MONOCYTE_AGEING | 4.44e-05 | 419 | 129 | 10 | MM3768 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN | 5.62e-05 | 197 | 129 | 7 | M10015 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP | 5.80e-05 | 198 | 129 | 7 | M5018 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 5.99e-05 | 199 | 129 | 7 | M7596 | |
| Coexpression | GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP | 6.14e-05 | 137 | 129 | 6 | M415 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_UP | 6.18e-05 | 200 | 129 | 7 | M4817 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 6.18e-05 | 200 | 129 | 7 | M9205 | |
| Coexpression | GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP | 6.18e-05 | 200 | 129 | 7 | M7365 | |
| Coexpression | PARK_HSC_MARKERS | 6.53e-05 | 44 | 129 | 4 | M6509 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 7.44e-05 | 206 | 129 | 7 | M2817 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 8.04e-05 | 450 | 129 | 10 | M39072 | |
| Coexpression | WEI_MIR34A_TARGETS | 8.73e-05 | 146 | 129 | 6 | M8617 | |
| Coexpression | GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP | 1.09e-04 | 152 | 129 | 6 | M343 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.15e-04 | 221 | 129 | 7 | M39222 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 1.20e-04 | 97 | 129 | 5 | M14698 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_UP | 1.32e-04 | 99 | 129 | 5 | M768 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 1.39e-04 | 481 | 129 | 10 | M3898 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_ENS_NEURONS | 1.49e-04 | 161 | 129 | 6 | M40214 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 1.50e-04 | 394 | 129 | 9 | MM3724 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | 1.56e-04 | 488 | 129 | 10 | M39104 | |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 1.65e-04 | 164 | 129 | 6 | M19957 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 1.99e-04 | 108 | 129 | 5 | MM1334 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 2.04e-04 | 323 | 129 | 8 | M9150 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | PRUNE2 NCOA3 ATRX MYCBP2 HSPA4L ARFGEF2 CHD9 XPC CYFIP2 CRACD UBXN4 ZZZ3 PSIP1 LONRF2 | 2.40e-04 | 946 | 129 | 14 | M39169 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.49e-04 | 177 | 129 | 6 | M39245 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | TBX3 PAG1 RBBP6 ACBD5 DGKH CREBBP PER2 INF2 PRKAA1 TCF25 MACF1 ZHX1 EP300 | 3.09e-04 | 854 | 129 | 13 | M1533 |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP | 3.54e-04 | 189 | 129 | 6 | M9978 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_T_CELL_AGEING | 3.68e-04 | 445 | 129 | 9 | MM3853 | |
| Coexpression | LEIN_NEURON_MARKERS | 3.78e-04 | 69 | 129 | 4 | M1712 | |
| Coexpression | LEIN_NEURON_MARKERS | 3.99e-04 | 70 | 129 | 4 | MM714 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 TCF4 LUC7L3 MYCBP2 HSPA4L RSF1 DZIP1 ZZZ3 MKI67 FGF13 ZHX1 | 4.10e-04 | 656 | 129 | 11 | M18979 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 4.46e-04 | 276 | 129 | 7 | M3063 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | TBX3 PAG1 RBBP6 ACBD5 DGKH CREBBP PER2 INF2 PRKAA1 TCF25 MACF1 ZHX1 EP300 | 4.48e-04 | 888 | 129 | 13 | MM1018 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | CMTR1 LUC7L3 MYCBP2 SMC1A NACA ARFGEF2 SPAG9 COG3 FHIP2A CREBBP CYB5B PRKAA1 TCF25 SF3B2 HTT | 4.50e-04 | 1129 | 129 | 15 | M42508 |
| Coexpression | GSE45365_CD8A_DC_VS_CD11B_DC_DN | 4.54e-04 | 198 | 129 | 6 | M9998 | |
| Coexpression | GSE14308_TH1_VS_NATURAL_TREG_DN | 4.66e-04 | 199 | 129 | 6 | M3381 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN | 4.66e-04 | 199 | 129 | 6 | M9332 | |
| Coexpression | GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN | 4.66e-04 | 199 | 129 | 6 | M7607 | |
| Coexpression | GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP | 4.66e-04 | 199 | 129 | 6 | M7984 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN | 4.66e-04 | 199 | 129 | 6 | M3626 | |
| Coexpression | CROMER_METASTASIS_UP | 4.69e-04 | 73 | 129 | 4 | M7061 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP | 4.78e-04 | 200 | 129 | 6 | M8112 | |
| Coexpression | GSE14308_TH17_VS_NATURAL_TREG_DN | 4.78e-04 | 200 | 129 | 6 | M3390 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 4.78e-04 | 200 | 129 | 6 | M8088 | |
| Coexpression | GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 4.78e-04 | 200 | 129 | 6 | M7618 | |
| Coexpression | GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP | 4.78e-04 | 200 | 129 | 6 | M4841 | |
| Coexpression | GSE27786_CD8_TCELL_VS_MONO_MAC_DN | 4.78e-04 | 200 | 129 | 6 | M4849 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN | 4.78e-04 | 200 | 129 | 6 | M10091 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN | 4.78e-04 | 200 | 129 | 6 | M8257 | |
| Coexpression | GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN | 4.78e-04 | 200 | 129 | 6 | M7868 | |
| Coexpression | GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN | 4.78e-04 | 200 | 129 | 6 | M7850 | |
| Coexpression | GSE27786_LIN_NEG_VS_CD4_TCELL_DN | 4.78e-04 | 200 | 129 | 6 | M4773 | |
| Coexpression | GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN | 4.78e-04 | 200 | 129 | 6 | M7356 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 5.17e-04 | 203 | 129 | 6 | MM3795 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | BDP1 TPR CMTR1 ATRX LUC7L3 GAP43 ATAD5 SMC1A IBSP ARFGEF2 MKI67 PALM3 MACF1 ASXL2 PHF10 | 4.36e-08 | 432 | 126 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | NCOA3 ATRX LUC7L3 DOCK11 SMC1A HJURP CHD9 FHIP2A CREBBP MEIS1 ANKRD11 HTT | 1.16e-07 | 281 | 126 | 12 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | NCOA3 ATRX LUC7L3 LCORL DOCK11 SMC1A HJURP RSF1 CHD9 CHGB RNF17 CREBBP MEIS1 NMT2 MIB1 ANKRD11 ABTB2 HTT TDRD12 | 2.86e-07 | 806 | 126 | 19 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | NCOA3 ATRX LUC7L3 DOCK11 SMC1A HJURP CHD9 CREBBP MEIS1 ANKRD11 HTT | 4.24e-07 | 259 | 126 | 11 | gudmap_developingGonad_e12.5_epididymis_k3_1000 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.36e-07 | 211 | 126 | 10 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_500 | 6.79e-07 | 84 | 126 | 7 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.18e-06 | 230 | 126 | 10 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BDP1 TPR CMTR1 ATRX MYCBP2 ATAD5 SMC1A ARFGEF2 CHD9 ZZZ3 MDC1 MKI67 MACF1 ASXL2 ZHX1 | 1.31e-06 | 564 | 126 | 15 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | TPR DENND2A ATRX LUC7L3 HSPA4L ATAD5 SMC1A RSF1 SKIDA1 CHD9 SPAG9 CHGB GPATCH8 RTN1 AMIGO1 CYFIP2 CRACD PSIP1 CELSR2 MKI67 PKIA PALM3 PHF14 PRDM16 | 1.50e-06 | 1370 | 126 | 24 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 1.71e-06 | 186 | 126 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | NCOA3 ATRX LUC7L3 SMC1A HJURP CHD9 FHIP2A CREBBP MEIS1 ANKRD11 | 2.40e-06 | 249 | 126 | 10 | gudmap_developingGonad_P2_epididymis_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | CMTR1 ATRX LUC7L3 SMC1A CHD9 GPATCH8 CYFIP2 CRACD CELSR2 MDC1 MKI67 SENP6 MACF1 ASXL2 EP300 | 2.53e-06 | 595 | 126 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | BDP1 ATRX LUC7L3 RBBP6 ATAD5 STXBP5L SMC1A ARFGEF2 MKI67 PALM3 PHF14 | 2.54e-06 | 311 | 126 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 5.65e-06 | 162 | 126 | 8 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.80e-06 | 275 | 126 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | BDP1 ATRX LUC7L3 HSPA4L RBBP6 ATAD5 STXBP5L SMC1A ARFGEF2 RTN1 CYFIP2 CRACD CELSR2 MKI67 PKIA PALM3 MAST1 PHF14 LONRF2 | 5.90e-06 | 989 | 126 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | BDP1 TPR TBX3 CMTR1 ATRX LUC7L3 GAP43 DOCK11 ATAD5 STXBP5L SMC1A IBSP ARFGEF2 MKI67 PALM3 MACF1 ASXL2 PRDM16 PHF10 | 5.90e-06 | 989 | 126 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | NCOA3 LUC7L3 DOCK11 SMC1A HJURP CHD9 FHIP2A MEIS1 ANKRD11 HTT | 7.70e-06 | 284 | 126 | 10 | gudmap_developingGonad_e16.5_epididymis_1000_k2 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_500 | 9.78e-06 | 125 | 126 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | LUC7L3 HSPA4L ATAD5 STXBP5L SMC1A ACBD5 RTN1 CYFIP2 CELSR2 NCOA1 | 1.17e-05 | 298 | 126 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.17e-05 | 298 | 126 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.33e-05 | 131 | 126 | 7 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.95e-05 | 192 | 126 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.95e-05 | 192 | 126 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | BDP1 TBX3 HSPA4L RBBP6 ATAD5 STXBP5L HJURP RTN1 CYFIP2 PSIP1 CELSR2 PKIA ANKRD11 PALM3 MAST1 PHF14 CHD6 PRDM16 | 2.03e-05 | 983 | 126 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | TPR ATRX LUC7L3 HSPA4L ATAD5 STXBP5L SMC1A ACBD5 RTN1 MEIS1 CYFIP2 CELSR2 PALM3 MAST1 NCOA1 MACF1 ASTN2 PRDM16 | 2.11e-05 | 986 | 126 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 CMTR1 ATRX LUC7L3 ATAD5 STXBP5L SMC1A ARFGEF2 CHD9 ZZZ3 MKI67 PALM3 MACF1 ASXL2 | 2.26e-05 | 629 | 126 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | TPR PAG1 SETD1B ATRX MYCBP2 RBBP6 ARFGEF2 DZIP1 CHGB RTN1 VCAN MIB1 FGF13 ASXL2 IRX2 SF3B2 | 2.32e-05 | 806 | 126 | 16 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | TBX3 PAG1 ATRX GAP43 MYCBP2 RBBP6 RSF1 ARFGEF2 DZIP1 CHGB CREBBP RTN1 VCAN MIB1 FGF13 ASXL2 | 2.77e-05 | 818 | 126 | 16 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.91e-05 | 203 | 126 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.48e-05 | 152 | 126 | 7 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | BDP1 TPR TCF4 TBX3 ATRX LUC7L3 IBSP ARFGEF2 DZIP1 MDC1 MKI67 PALM3 MACF1 PHF14 ABTB2 | 3.57e-05 | 744 | 126 | 15 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | PAG1 HSPA4L STXBP5L RTN1 CYFIP2 CRACD MAST1 NCOA1 MACF1 ASTN2 CHD6 ELK4 LONRF2 PRDM16 | 3.76e-05 | 659 | 126 | 14 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.18e-05 | 277 | 126 | 9 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | BDP1 ATRX LUC7L3 HSPA4L ATAD5 STXBP5L SMC1A ARFGEF2 RTN1 CYFIP2 CELSR2 PALM3 | 4.20e-05 | 498 | 126 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.30e-05 | 278 | 126 | 9 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BDP1 TPR ATRX LUC7L3 HSPA4L RBBP6 ATAD5 SMC1A RSF1 ARFGEF2 CHD9 RTN1 CYFIP2 CRACD PSIP1 MDC1 MKI67 PKIA PALM3 MACF1 PHF14 PRDM16 | 4.51e-05 | 1459 | 126 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR ATRX LUC7L3 ATAD5 SMC1A SKIDA1 CHD9 RTN1 CYFIP2 CRACD PSIP1 CELSR2 MKI67 PKIA MACF1 PHF14 IRX2 PRDM16 | 5.44e-05 | 1060 | 126 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.12e-05 | 291 | 126 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 6.75e-05 | 116 | 126 | 6 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NCOA3 ATRX LUC7L3 LCORL DOCK11 SMC1A HJURP CHD9 FHIP2A CREBBP MEIS1 NMT2 ANKRD11 TCF25 HTT | 7.03e-05 | 790 | 126 | 15 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 7.51e-05 | 371 | 126 | 10 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | CDS1 ATRX MYCBP2 ARFGEF2 IGSF5 MEIS1 CELSR2 NMT2 MIB1 PAM ASXL2 IRX2 PRDM16 ZHX1 SF3B2 | 7.54e-05 | 795 | 126 | 15 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | PAG1 LUC7L3 HSPA4L ATAD5 STXBP5L SMC1A ACBD5 RTN1 CYFIP2 MAST1 NCOA1 ASTN2 CHD6 ELK4 LONRF2 PRDM16 | 7.86e-05 | 893 | 126 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | NCOA3 ATRX LUC7L3 LCORL DOCK11 SMC1A HJURP CHD9 FHIP2A CREBBP MEIS1 NMT2 ANKRD11 TCF25 HTT | 7.98e-05 | 799 | 126 | 15 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NCOA3 ATRX LUC7L3 LCORL DOCK11 SMC1A HJURP CHD9 FHIP2A CREBBP MEIS1 NMT2 ANKRD11 TCF25 HTT | 8.20e-05 | 801 | 126 | 15 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | NCOA3 ATRX LUC7L3 LCORL DOCK11 HJURP CHD9 RNF17 CREBBP MEIS1 NMT2 MIB1 ANKRD11 ASXL2 TDRD12 | 8.55e-05 | 804 | 126 | 15 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_top-relative-expression-ranked_1000 | TBX3 GAP43 IGSF5 CHGB GPATCH8 CHRM2 RTN1 MEIS1 CYFIP2 PKIA MAST1 PAM ASTN2 FGF13 LONRF2 | 1.17e-04 | 827 | 126 | 15 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 ATRX LUC7L3 RBBP6 ATAD5 STXBP5L SMC1A COG3 CYFIP2 CRACD BRD9 MKI67 PALM3 PHF14 LONRF2 | 1.23e-04 | 831 | 126 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.35e-04 | 323 | 126 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | ATRX LCORL SMC1A HJURP CHGB RNF17 MEIS1 ANKRD11 ABTB2 TDRD12 | 1.48e-04 | 403 | 126 | 10 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | NCOA3 ATRX LCORL DOCK11 HJURP CHD9 CREBBP MEIS1 NMT2 ANKRD11 | 1.57e-04 | 406 | 126 | 10 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_200 | 1.59e-04 | 46 | 126 | 4 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 1.67e-04 | 409 | 126 | 10 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.10e-04 | 91 | 126 | 5 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | NCOA3 ATRX LCORL DOCK11 HSPA4L STRA8 HJURP CHD9 RNF17 NMT2 MIB1 ASXL2 ABTB2 TDRD12 | 2.11e-04 | 776 | 126 | 14 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_top-relative-expression-ranked_500 | 2.14e-04 | 422 | 126 | 10 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | ATRX LCORL HSPA4L HJURP RNF17 CREBBP NMT2 MIB1 ANKRD11 ASXL2 LONRF2 PRDM16 ABTB2 TDRD12 | 2.17e-04 | 778 | 126 | 14 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | 2.36e-04 | 427 | 126 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TPR ATRX LUC7L3 HSPA4L ATAD5 SMC1A SKIDA1 CHD9 CHGB RTN1 CYFIP2 CRACD PSIP1 CELSR2 MKI67 PKIA MACF1 PHF14 IRX2 PRDM16 | 2.46e-04 | 1414 | 126 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.65e-04 | 279 | 126 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.69e-04 | 211 | 126 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 2.76e-04 | 150 | 126 | 6 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_200 | 2.76e-04 | 53 | 126 | 4 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k1_200 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | NCOA3 ATRX LUC7L3 LCORL SMC1A HJURP CHD9 FHIP2A CREBBP MEIS1 NMT2 ANKRD11 TCF25 PRDM16 | 2.77e-04 | 797 | 126 | 14 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_top-relative-expression-ranked_100 | 2.83e-04 | 97 | 126 | 5 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 2.97e-04 | 98 | 126 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_top-relative-expression-ranked_500 | 2.99e-04 | 440 | 126 | 10 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | NCOA3 ATRX GAP43 LCORL DOCK11 HJURP CHD9 CHGB CREBBP MEIS1 NMT2 MIB1 PRDM16 ABTB2 | 3.47e-04 | 815 | 126 | 14 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.62e-04 | 369 | 126 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.76e-04 | 223 | 126 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | TPR ATRX LUC7L3 GAP43 ATAD5 SMC1A RSF1 ARFGEF2 CHD9 DZIP1 RTN1 PSIP1 SNX25 VCAN MKI67 MACF1 PHF14 PHF10 | 3.85e-04 | 1241 | 126 | 18 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.97e-04 | 225 | 126 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TCF4 TBX3 PAG1 LCORL CDKN2AIP RSF1 ETV3 COG3 PSIP1 VCAN MIB1 FGF13 ASXL2 ABTB2 | 4.47e-04 | 836 | 126 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BDP1 TPR ATRX LUC7L3 RBBP6 ATAD5 SMC1A RSF1 ARFGEF2 CHD9 CRACD PSIP1 MDC1 MKI67 PKIA MACF1 PHF14 PRDM16 | 4.48e-04 | 1257 | 126 | 18 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.53e-04 | 230 | 126 | 7 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 4.93e-04 | 469 | 126 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | PAG1 STXBP5L HJURP RTN1 CELSR2 MAST1 NCOA1 PAM ASTN2 CHD6 ELK4 LONRF2 PRDM16 | 5.04e-04 | 747 | 126 | 13 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_top-relative-expression-ranked_1000 | TBX3 GAP43 HSPA4L IGSF5 CHGB CHRM2 RTN1 CYFIP2 PKIA MAST1 ASTN2 FGF13 MAP3K13 LONRF2 | 5.09e-04 | 847 | 126 | 14 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RBBP6 ATAD5 STXBP5L CYFIP2 CELSR2 NCOA1 PAM PHF14 CHD6 ELK4 LONRF2 ABTB2 | 5.24e-04 | 654 | 126 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_100 | 5.38e-04 | 27 | 126 | 3 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k2_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | PAG1 STXBP5L HJURP RTN1 MAST1 NCOA1 PAM ASTN2 CHD6 ELK4 LONRF2 PRDM16 | 5.53e-04 | 658 | 126 | 12 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.57e-04 | 312 | 126 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 6.26e-04 | 175 | 126 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | CMTR1 ATRX GAP43 HSPA4L SMC1A HJURP GMIP RTN1 CYFIP2 CRACD CELSR2 MAST1 MACF1 ASXL2 PRDM16 | 7.01e-04 | 979 | 126 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.14e-04 | 492 | 126 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | BDP1 TBX3 DOCK11 ATAD5 STXBP5L IBSP MKI67 PALM3 PRDM16 PHF10 | 7.14e-04 | 492 | 126 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 7.25e-04 | 249 | 126 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 NCOA3 ATRX RBBP6 SMC1A ARFGEF2 COG3 BRD9 MKI67 PALM3 MACF1 PHF14 PHF10 | 7.53e-04 | 780 | 126 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.03e-04 | 330 | 126 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | TBX3 CDS1 LUC7L3 MYCBP2 HJURP ARFGEF2 ETV3 IGSF5 CYFIP2 VCAN MIB1 ASXL2 PRDM16 | 8.08e-04 | 786 | 126 | 13 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_2500_k-means-cluster#1 | PHF23 ATAD5 CDKN2AIP HJURP CHD9 COG3 CYB5B CRACD PRDM10 CYREN BRD9 ASXL2 METTL8 PRDM15 PHF10 | 8.10e-04 | 993 | 126 | 15 | ratio_EB-blastocyst_vs_EB-fibro_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 8.12e-04 | 413 | 126 | 9 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 8.37e-04 | 185 | 126 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | TCF4 TBX3 DOCK11 RBBP6 HJURP DZIP1 CHGB MEIS1 PSIP1 PKIA ANKRD11 PAM PHF10 | 8.56e-04 | 791 | 126 | 13 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | ATRX LUC7L3 LCORL DOCK11 HJURP CHD9 RNF17 CREBBP MEIS1 NMT2 ANKRD11 LONRF2 HTT | 8.96e-04 | 795 | 126 | 13 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 9.12e-04 | 259 | 126 | 7 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.54e-04 | 261 | 126 | 7 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_100 | 9.56e-04 | 8 | 126 | 2 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_500 | 9.69e-04 | 127 | 126 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_500 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-10 | 187 | 129 | 10 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-09 | 184 | 129 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.88e-09 | 186 | 129 | 9 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 6.14e-09 | 196 | 129 | 9 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 6.14e-09 | 196 | 129 | 9 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.42e-09 | 197 | 129 | 9 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-08 | 182 | 129 | 8 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-08 | 182 | 129 | 8 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-08 | 188 | 129 | 8 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-08 | 191 | 129 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-08 | 191 | 129 | 8 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-08 | 191 | 129 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-07 | 194 | 129 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.28e-07 | 200 | 129 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-06 | 184 | 129 | 7 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 185 | 129 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 186 | 129 | 7 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.39e-06 | 190 | 129 | 7 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.44e-06 | 191 | 129 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.44e-06 | 191 | 129 | 7 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.44e-06 | 191 | 129 | 7 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.54e-06 | 193 | 129 | 7 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 1.59e-06 | 194 | 129 | 7 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.71e-06 | 196 | 129 | 7 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-06 | 198 | 129 | 7 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.83e-06 | 198 | 129 | 7 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.07e-05 | 171 | 129 | 6 | d339840626211a7bf1a9eb8f14d6c9509ab05e1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 171 | 129 | 6 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 173 | 129 | 6 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 173 | 129 | 6 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-ILC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.18e-05 | 174 | 129 | 6 | 7c50bf9da37711266cc077eef4e54b58463f1d37 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 176 | 129 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.26e-05 | 176 | 129 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 178 | 129 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.34e-05 | 178 | 129 | 6 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | C_00|World / shred on cell type and cluster | 1.38e-05 | 179 | 129 | 6 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 182 | 129 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 182 | 129 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 1.62e-05 | 184 | 129 | 6 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 1.67e-05 | 185 | 129 | 6 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 188 | 129 | 6 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.83e-05 | 188 | 129 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.88e-05 | 189 | 129 | 6 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.88e-05 | 189 | 129 | 6 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.94e-05 | 190 | 129 | 6 | b1095b2a7467c152d16e4f19a9515aeb61fc9e3d | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.00e-05 | 191 | 129 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.06e-05 | 192 | 129 | 6 | 7a90ec9fc8f29216c4828e0cf5d040906456e53b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.06e-05 | 192 | 129 | 6 | d883b91bbab71673de4858346d3ab33e5fbbf842 | |
| ToppCell | 11.5-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 2.06e-05 | 192 | 129 | 6 | a77d3692ff02ef7e066a9bd9e22725055a25c4d4 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.06e-05 | 192 | 129 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.06e-05 | 192 | 129 | 6 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 2.12e-05 | 193 | 129 | 6 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.12e-05 | 193 | 129 | 6 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | 18-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 2.18e-05 | 194 | 129 | 6 | d3c90e1f1228f8ba0ba56105c6cf4f302c388f28 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 2.18e-05 | 194 | 129 | 6 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 195 | 129 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-05 | 195 | 129 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-05 | 197 | 129 | 6 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.38e-05 | 197 | 129 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-05 | 197 | 129 | 6 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.38e-05 | 197 | 129 | 6 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-05 | 197 | 129 | 6 | 29b0a5927f80455eef7b793feabef69fba1a3df1 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.44e-05 | 198 | 129 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.51e-05 | 199 | 129 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.51e-05 | 199 | 129 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-05 | 199 | 129 | 6 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.51e-05 | 199 | 129 | 6 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.51e-05 | 199 | 129 | 6 | a255484ba77bd2741a541da278efc8cf4abbe570 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.51e-05 | 199 | 129 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.59e-05 | 200 | 129 | 6 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-Neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-05 | 200 | 129 | 6 | b9538eb33ac86384e7e289a5a82fac4d56a7b9c2 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-Treg|COVID-19_Severe / Disease, condition lineage and cell class | 2.59e-05 | 200 | 129 | 6 | 2b363f2a1d08019b6ff0b10419870049063cc1cf | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-05 | 200 | 129 | 6 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-05 | 200 | 129 | 6 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-ILC|Multiple_Sclerosis / Disease, condition lineage and cell class | 2.59e-05 | 200 | 129 | 6 | ab9bdc9365cbdffe4ed246ce0c8a008a390e387e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Intermediate|1m / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-05 | 200 | 129 | 6 | 805f50236113713b02f77aa5e208efb3b3b959d5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-05 | 200 | 129 | 6 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Interneuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-05 | 200 | 129 | 6 | c7e33057466915d4e2b34f2062b22d9cdffa69dc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.59e-05 | 200 | 129 | 6 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | LPS_only-Endothelial-Epi-like|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 126 | 129 | 5 | 4c598f7bae09aca7a4ecce63dfd6890b26468c73 | |
| ToppCell | LPS_only-Endothelial-Epi-like-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 126 | 129 | 5 | e065304f480a5e38532b66508b0ee87cc48bba9b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 7.14e-05 | 148 | 129 | 5 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.85e-05 | 151 | 129 | 5 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f | |
| ToppCell | Striatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.43e-05 | 157 | 129 | 5 | c41ff3fe9de7187575114febfe9bd8733366fb8a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 159 | 129 | 5 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 159 | 129 | 5 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 171 | 129 | 5 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 171 | 129 | 5 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-04 | 175 | 129 | 5 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 175 | 129 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-04 | 175 | 129 | 5 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-04 | 175 | 129 | 5 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.61e-04 | 176 | 129 | 5 | 76fdf211bce101e83a27d822cb399487bd107027 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.65e-04 | 177 | 129 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 177 | 129 | 5 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-04 | 178 | 129 | 5 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.70e-04 | 178 | 129 | 5 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 178 | 129 | 5 | 742ee0cb8cb585a5e34bd5b20aebe9bb99756e0c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 178 | 129 | 5 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 179 | 129 | 5 | 228d12ed1c8dc92aefbcea4aaf7d108783c22be0 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.85e-06 | 50 | 81 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | torcetrapib | TPR NCOA3 TCF4 ATRX RBBP6 SMC1A CHD9 CYREN UBXN4 PER2 ANKRD11 LONRF2 | 5.91e-07 | 342 | 129 | 12 | ctd:C483909 |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.90e-06 | 197 | 129 | 9 | 2103_UP | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; HL60; HT_HG-U133A | 1.98e-06 | 198 | 129 | 9 | 2334_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 8.47e-06 | 179 | 129 | 8 | 4585_DN | |
| Drug | Condelphine [7633-69-4]; Down 200; 8.8uM; HL60; HT_HG-U133A | 1.64e-05 | 196 | 129 | 8 | 2976_DN | |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.89e-05 | 200 | 129 | 8 | 6679_DN | |
| Disease | Malignant neoplasm of breast | NCOA3 TBX3 CDS1 IBSP ARFGEF2 MFSD9 COG3 MEIS1 PER2 PRKAA1 MKI67 NCOA1 MACF1 ASTN2 MAP3K13 MAGEC2 EP300 | 4.19e-06 | 1074 | 128 | 17 | C0006142 |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.87e-05 | 2 | 128 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 1.87e-05 | 2 | 128 | 2 | cv:C4551859 | |
| Disease | diabetes mellitus, family history | 1.87e-05 | 2 | 128 | 2 | EFO_0000400, EFO_0000493 | |
| Disease | Menke-Hennekam syndrome | 1.87e-05 | 2 | 128 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 1.87e-05 | 2 | 128 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 1.87e-05 | 2 | 128 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 1.87e-05 | 2 | 128 | 2 | C4551859 | |
| Disease | periodic limb movement disorder | 1.87e-05 | 2 | 128 | 2 | EFO_0007428 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 1.87e-05 | 2 | 128 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 1.87e-05 | 2 | 128 | 2 | C0035934 | |
| Disease | migraine disorder, Headache | 3.73e-05 | 86 | 128 | 5 | HP_0002315, MONDO_0005277 | |
| Disease | Adenoid Cystic Carcinoma | 7.69e-05 | 100 | 128 | 5 | C0010606 | |
| Disease | anthropometric measurement | 9.52e-05 | 168 | 128 | 6 | EFO_0004302 | |
| Disease | insomnia measurement | 1.41e-04 | 443 | 128 | 9 | EFO_0007876 | |
| Disease | Insulinogenic index measurement | 1.85e-04 | 5 | 128 | 2 | EFO_0009961 | |
| Disease | Restless Legs Syndrome | 1.85e-04 | 5 | 128 | 2 | C0035258 | |
| Disease | sleep duration | 1.89e-04 | 362 | 128 | 8 | EFO_0005271 | |
| Disease | breast carcinoma (is_marker_for) | 1.98e-04 | 66 | 128 | 4 | DOID:3459 (is_marker_for) | |
| Disease | Bladder Neoplasm | 3.71e-04 | 140 | 128 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.83e-04 | 141 | 128 | 5 | C0005684 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 3.87e-04 | 7 | 128 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | catalase measurement | 3.87e-04 | 7 | 128 | 2 | EFO_0008071 | |
| Disease | Epilepsy, Cryptogenic | 4.55e-04 | 82 | 128 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 4.55e-04 | 82 | 128 | 4 | C0751111 | |
| Disease | Aura | 4.55e-04 | 82 | 128 | 4 | C0236018 | |
| Disease | restless legs syndrome (implicated_via_orthology) | 5.14e-04 | 8 | 128 | 2 | DOID:0050425 (implicated_via_orthology) | |
| Disease | repulsive guidance molecule A measurement | 6.59e-04 | 9 | 128 | 2 | EFO_0008273 | |
| Disease | lung cancer (implicated_via_orthology) | 6.59e-04 | 9 | 128 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | 6.82e-04 | 550 | 128 | 9 | EFO_0004346, EFO_0004464 | |
| Disease | Neurodevelopmental Disorders | 7.32e-04 | 93 | 128 | 4 | C1535926 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.53e-04 | 41 | 128 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 7.53e-04 | 41 | 128 | 3 | C0858252 | |
| Disease | Carcinoma, Transitional Cell | 7.53e-04 | 41 | 128 | 3 | C0007138 | |
| Disease | PR segment | 8.21e-04 | 10 | 128 | 2 | EFO_0005095 | |
| Disease | waist-hip ratio | PRUNE2 CPAMD8 MYCBP2 LCORL CHRM2 MEIS1 CYB5B CTCFL PAM ASTN2 FGF13 LONRF2 PRDM16 HTT | 8.98e-04 | 1226 | 128 | 14 | EFO_0004343 |
| Disease | cognitive function measurement, self reported educational attainment | 9.37e-04 | 355 | 128 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | migraine disorder | 9.68e-04 | 357 | 128 | 7 | MONDO_0005277 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 1.00e-03 | 11 | 128 | 2 | EFO_0801871 | |
| Disease | alcohol consumption measurement | TCF4 LCORL CHRM2 HMG20A CYB5B MEI4 ZZZ3 ANKRD11 SENP6 ASTN2 ASXL2 PRDM16 EP300 HTT | 1.02e-03 | 1242 | 128 | 14 | EFO_0007878 |
| Disease | Epilepsy | 1.32e-03 | 109 | 128 | 4 | C0014544 | |
| Disease | PR interval | 1.47e-03 | 495 | 128 | 8 | EFO_0004462 | |
| Disease | Prostatic Neoplasms | 1.50e-03 | 616 | 128 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.50e-03 | 616 | 128 | 9 | C0376358 | |
| Disease | taste liking measurement | 1.56e-03 | 388 | 128 | 7 | EFO_0010155 | |
| Disease | receptive language perception, parental genotype effect measurement | 1.64e-03 | 14 | 128 | 2 | EFO_0005686, EFO_0005939 | |
| Disease | early cardiac repolarization measurement | 1.64e-03 | 14 | 128 | 2 | EFO_0004885 | |
| Disease | Left ventricular noncompaction | 1.64e-03 | 14 | 128 | 2 | C1960469 | |
| Disease | pain | 1.68e-03 | 196 | 128 | 5 | EFO_0003843 | |
| Disease | hippocampal atrophy | 1.87e-03 | 56 | 128 | 3 | EFO_0005039 | |
| Disease | optic disc size measurement | 2.04e-03 | 205 | 128 | 5 | EFO_0004832 | |
| Disease | white matter hyperintensity measurement | 2.09e-03 | 302 | 128 | 6 | EFO_0005665 | |
| Disease | Squamous cell carcinoma | 2.12e-03 | 124 | 128 | 4 | C0007137 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2.39e-03 | 61 | 128 | 3 | C1961102 | |
| Disease | Huntington Disease | 2.43e-03 | 17 | 128 | 2 | C0020179 | |
| Disease | Breast Carcinoma | 2.46e-03 | 538 | 128 | 8 | C0678222 | |
| Disease | Seizures | 2.67e-03 | 218 | 128 | 5 | C0036572 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 2.73e-03 | 18 | 128 | 2 | EFO_1000649, HP_0000131 | |
| Disease | neutrophil count | PRUNE2 CPAMD8 MYCBP2 IQSEC2 ETV3 CHD9 DGKH CREBBP HMG20A UBXN4 ANKRD11 NCOA1 PAM HTT | 2.74e-03 | 1382 | 128 | 14 | EFO_0004833 |
| Disease | Headache | 2.74e-03 | 64 | 128 | 3 | HP_0002315 | |
| Disease | Antimigraine preparation use measurement | 3.71e-03 | 21 | 128 | 2 | EFO_0009939 | |
| Disease | progranulin measurement | 4.07e-03 | 22 | 128 | 2 | EFO_0004625 | |
| Disease | creatinine measurement | TCF4 CHD9 DGKH MEIS1 ZZZ3 CELSR2 MYPN ANKRD11 ASTN2 ASXL2 TDRD12 | 4.10e-03 | 995 | 128 | 11 | EFO_0004518 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGSDSGVSDSEESVF | 46 | Q14137 | |
| SEKSEATDGGFTSQI | 676 | Q96QE3 | |
| ENSDEDSSGESKGES | 126 | A1L162 | |
| ENTSNESTDVTKGDS | 1531 | Q09472 | |
| STEKTGGDNDVEESS | 71 | A6H8Y1 | |
| GEVETDLKATGNESS | 951 | A6H8Y1 | |
| DEVTNGTVSVSKDGS | 311 | Q86WK6 | |
| GKATSGKFEQSTEET | 321 | Q9BXX2 | |
| AAGGDHETESTSDKE | 26 | Q92903 | |
| SDEEDASVTVGTGEK | 411 | Q6UB99 | |
| KEEEGTTGTASTFEV | 1726 | P13611 | |
| NGDEAAAEEASTTKG | 611 | Q8NI51 | |
| DEAKVGDTLGDSSSS | 471 | Q9H8M2 | |
| TVNGKAESSDSGAES | 186 | Q5T8D3 | |
| ASGQESSNGTDRKTE | 176 | P41162 | |
| ARSDSGKVSTENGDA | 256 | Q9Y6D5 | |
| SSLSGTDDGAQEVVK | 276 | Q9Y6D5 | |
| ASETTEGSQGDSKNA | 1571 | Q92793 | |
| LSTEGSDQEKEDDGS | 941 | P19021 | |
| QGEEKESSNDSTSVS | 276 | P08172 | |
| SIKAGTVDEDSSGSE | 2901 | Q9HCU4 | |
| ETTQSEEEEKSGLGA | 26 | Q5RIA9 | |
| RAKGTSGSEADDETQ | 396 | O75129 | |
| VKELSEGSEESSDGQ | 91 | Q76L83 | |
| GADSKSGEVDATSDQ | 111 | Q8NCD3 | |
| TEQSGEAQGEAAKSE | 61 | P61925 | |
| GGEESLETEKTQGTE | 521 | A6NDB9 | |
| EDELSDVSQGGSKAT | 261 | O60271 | |
| ATEATEGNAGSAEDT | 891 | O60271 | |
| EGGSKSDSEDITRSA | 191 | O00470 | |
| HTSSGSSSEEEDSGK | 101 | Q9BWK5 | |
| ESQAGSDTDVEEGKA | 371 | Q14676 | |
| SFSEESSSQKGEDTG | 111 | Q9UBF1 | |
| SGGTKSDSASDSQEI | 61 | O60551 | |
| QKTGTEAEAADSGAV | 26 | Q8NBP5 | |
| VAEDTKDGGGEVSSQ | 836 | Q9P107 | |
| DEDGSKESNDLATTG | 16 | Q9NP66 | |
| KSDGENSRTVSVEGD | 236 | Q5JU85 | |
| VSSGSSEIKSDDEGD | 506 | P15884 | |
| SKNGTVDGTSENTED | 491 | Q8N3X6 | |
| QVTTAGSGKASEAEA | 221 | Q9NXV6 | |
| ETTQSEEEEKSGLGA | 26 | Q8IUF1 | |
| ETTQSEEEEKSGLGA | 26 | Q9BRT8 | |
| KVSEESDESGTSDQD | 211 | Q9H3M9 | |
| DKDESATNSGTGATA | 231 | Q9UKJ3 | |
| GLSEVSDTKEDENGS | 1231 | O15055 | |
| GESGKTGAETITEAT | 7041 | Q7Z5P9 | |
| AGEVEKGVDASDSTA | 176 | A6H8Z2 | |
| DDSGSGSKTEQSVAL | 2531 | O94854 | |
| VNGTSEDIKSEGDTQ | 416 | O95232 | |
| LEEGDAGSSENSSEK | 346 | Q1L5Z9 | |
| STADDSKDSVAQGTT | 166 | P46013 | |
| ITSENGEKSDDGTQD | 416 | Q9NQV6 | |
| AKEGSTGTSESSVEA | 286 | Q96P66 | |
| VVTGSGLDSQKSDEE | 371 | Q96F07 | |
| SSSEESLGESKEQLG | 586 | Q86XP1 | |
| EDSRKAEGSTGTSSV | 471 | Q969R2 | |
| KDSGEGSCSDSEENI | 51 | O94880 | |
| KSFSEDAVTDSSGSG | 1191 | Q27J81 | |
| KAQEGTETSAEDEGI | 206 | Q9BZI1 | |
| ETQGEGTSSAGDSEA | 841 | Q9Y2H9 | |
| SESNVSVKEEESSGN | 1646 | Q7Z6E9 | |
| GKSSEDATDDISSGN | 916 | Q86YT6 | |
| DGESTSGTEDIKIQF | 106 | O43283 | |
| KGTSDSSSGNVSEGE | 316 | Q8WUB8 | |
| TSSDSDSEEEEGKQT | 236 | Q99613 | |
| TSSDSDSEEEEGKQT | 236 | B5ME19 | |
| GDGSSGTEQEVESSS | 546 | P46100 | |
| EGKTERTESQSSENG | 2751 | Q3L8U1 | |
| NSTDEGSEKADASSG | 2866 | Q3L8U1 | |
| DGDSTSTLEEHSEGK | 1716 | P42858 | |
| TNKETETESGNENSG | 326 | Q9NSI5 | |
| VETAQDDETSSQGKA | 286 | Q5JSL3 | |
| SGKVTDENSESDSDT | 511 | Q9ULE3 | |
| SEVSSSSKDVENGGK | 111 | P28324 | |
| DEKSLSAEQGVTDGT | 1316 | Q8TD26 | |
| TESSSDGGDGVFSEK | 1356 | Q8TD26 | |
| EEGESNSLTKSGSTE | 521 | Q96JB2 | |
| GGTETSKQSTEAESI | 731 | Q6ZU35 | |
| ETGTASEEERGSTDK | 1281 | Q8IZJ3 | |
| SGSDGKGQEVETSVT | 11 | O43169 | |
| ETTQSEEEEKSGLGA | 26 | Q5JTY5 | |
| ETTQSEEEEKSGLGA | 26 | Q4V339 | |
| DGTIDGTKDEDSTYT | 86 | Q92913 | |
| SSGGDVFKVTTDSDT | 321 | Q9UJ99 | |
| EDDSSSGEEAAGKTN | 416 | Q03111 | |
| EDTLKGQDSLSTDTG | 191 | Q5W0V3 | |
| SSQKEENSEESGTGD | 561 | Q96Q07 | |
| ESEGSGSEKSSAASE | 861 | Q96T23 | |
| SREKSSQESGEETGS | 231 | P05060 | |
| YEKSSGSSEGQSKTE | 156 | Q9H825 | |
| SGSDSETEGKQHSSD | 51 | Q8N1G2 | |
| KETEEGNTSSIGHDD | 326 | A8MW99 | |
| SAAESQGKGSISEDE | 341 | Q16799 | |
| DEISGQGASSQDTKT | 381 | Q9BZY9 | |
| KENGTSDESSSEQAA | 331 | O15119 | |
| DGQSESEKEAQGATD | 1321 | Q8WUY3 | |
| GSAETESATKASTDN | 136 | P17677 | |
| KASITSGEVTEENGE | 511 | Q9H3E2 | |
| TGAEGGAESKTSSEN | 1146 | Q587J7 | |
| DDDVQKSDISSSSQG | 91 | Q15788 | |
| KETEFTGSVGDETNS | 1326 | P57071 | |
| DTTTGTGSDLDSDVD | 616 | Q9HAZ2 | |
| KTETSEEGSGDLDNL | 786 | Q9Y6Q9 | |
| GKTETNEGTLDDFTV | 811 | Q1XH10 | |
| AEDTTETGRQGKGTS | 211 | P21815 | |
| SSTTKAASGTEAGEE | 541 | Q9ULL8 | |
| KVQEAQDSDSDSEGG | 16 | Q8IXJ6 | |
| DIAKSQDAEVGDGTT | 81 | Q99832 | |
| SGGEEDEKESLSASS | 1031 | Q9UPS6 | |
| ASKNSVQSGESDSDE | 171 | O75592 | |
| GGEAEESATDTTSET | 276 | Q9NWQ8 | |
| TVKSDADGTEGSEIE | 716 | Q86YF9 | |
| SGSTNTVASEGVTKD | 591 | Q9Y2K9 | |
| EGSVKDSGVDSQGAS | 221 | Q7Z7C7 | |
| VEESDASSQGSGSEG | 691 | Q8N961 | |
| AAEESSSQETSKGLG | 861 | P55201 | |
| SDSDAEAQGKSSEVS | 506 | Q13131 | |
| KTGVTSTSDSEEEGD | 266 | O75475 | |
| TDDSGVSGESESESL | 1446 | Q9BXT8 | |
| GVSSESSGDREKDST | 341 | Q13435 | |
| DKAEATEEGDGTQTT | 51 | Q5GAN6 | |
| LSTTNETATGDDGDE | 2251 | P12270 | |
| DGQSGTETKSDSTKD | 811 | O95757 | |
| EGVDDTSSSEGSTVD | 1076 | Q9Y5Y9 | |
| EASTGGEATQETGKE | 106 | Q9C0C2 | |
| EIDESNAGSSKEEAG | 631 | Q9UKY1 | |
| SQEEGSSQGEDSVSG | 951 | Q14683 | |
| ESEGDTDKDGTNLLS | 41 | Q9GZR1 | |
| KEVGSTETSQDGDAS | 301 | Q9BUL5 | |
| GLSSDEEEGTSSQAE | 881 | Q01831 | |
| SDTKSDTATGGESAG | 161 | Q92575 | |
| EKSVAENGDTDTQTS | 236 | Q8IYH5 | |
| KSSTGEASENGLEDI | 136 | Q9BQ70 | |
| SQGKAEASATDAGDE | 186 | Q8WY91 | |
| QGAFTSDDAVDTEGT | 96 | P22415 | |
| DEENGDELKSSTGSA | 711 | Q8WXH2 | |
| VTKNNKGSGTESDSD | 1881 | E9PAV3 | |
| DKGSEASSEAGVVTT | 606 | Q86TC9 |